State-of-the-Art of 3D Cultures (Organs-on-a-Chip) in Safety Testing and Pathophysiology by Alepee, Natalie et al.
Altex 31, 4/14 441
t4 Workshop Report*
State-of-the-Art of 3D Cultures  
(Organs-on-a-Chip) in Safety Testing  
and Pathophysiology 
Natalie Alépée 1, Anthony Bahinski 2, Mardas Daneshian 3, Bart De Wever 4, Ellen Fritsche 5,  
Alan Goldberg 6, Jan Hansmann 7, Thomas Hartung 3,6, John Haycock 8, Helena T. Hogberg 6,  
Lisa Hoelting 9, Jens M. Kelm 10, Suzanne Kadereit 9, Emily McVey 11, Robert Landsiedel 12,  
Marcel Leist 3,9, Marc Lübberstedt 13, Fozia Noor 14, Christian Pellevoisin 1, Dirk Petersohn 15,  
Uwe Pfannenbecker 16, Kerstin Reisinger 15, Tzutzuy Ramirez 12, Barbara Rothen-Rutishauser 17,  
Monika Schäfer-Korting 18, Katrin Zeilinger 13 and Marie-Gabriele Zurich 19,20
1l’Oréal R&I, Aulnay, France; 2Wyss Institute for Biologically Inspired engineering, Harvard University, Boston, USA; 3Center 
for Alternatives to Animal testing – europe (CAAt-europe), University of Konstanz, Konstanz, Germany; 4the Alexandra 
Association, Monaco; 5leibniz Research Institute for environmental Medicine, Duesseldorf, Germany; 6Center for Alternatives 
to Animal testing (CAAt), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, USA; 7Department 
of tissue engineering and Regenerative Medicine, University Hospital Wuerzburg, Wuerzburg, Germany; 8Department of 
Materials Science of Engineering, University of Sheffield, Sheffield, UK; 
9Doerenkamp-Zbinden Chair of in vitro toxicology and 
Biomedicine, University of Konstanz, Konstanz, Germany; 10InSphero AG, Schlieren, Switzerland; 11Board for the Authorization 
of Plant Protection Products and Biocides, Wageningen, the Netherlands; 12BASF Se, experimental toxicology and ecology, 
ludwigshafen, Germany; 13Bioreactor Group, Berlin-Brandenburg Center for Regenerative therapies (BCRt), Charité Campus 
Virchow-Klinikum, Berlin, Germany; 14Biochemical engineering, Saarland University, Saarbruecken, Germany; 15Henkel AG 
& Co KGaA, Duesseldorf, Germany; 16Beiersdorf AG, Hamburg, Germany; 17Adolphe Merkle Institute, University of Fribourg, 
Switzerland; 18Institute for Pharmacy (Pharmacology and toxicology), Freie Universität Berlin, Berlin, Germany; 19Department 
of Physiology, Faculty of Biology and Medicine, University of lausanne, lausanne, Switzerland; 20Swiss Center for Applied 
Human toxicology (SCAHt), University of lausanne, lausanne, Switzerland 
Received June 11, 2014; Epub July 14, 2014; http://dx.doi.org/10.14573/altex1406111
* a report of t4 – the transatlantic think tank for toxicology, a collaboration of the toxicologically oriented chairs in Baltimore, Konstanz 
and Utrecht sponsored by the Doerenkamp-Zbinden Foundation; participants do not represent their institutions and do not necessarily 
endorse all recommendations made.
Summary
Integrated approaches using different in vitro methods in combination with bioinformatics can (i) increase 
the success rate and speed of drug development; (ii) improve the accuracy of toxicological risk assessment; 
and (iii) increase our understanding of disease. Three-dimensional (3D) cell culture models are important 
building blocks of this strategy which has emerged during the last years. The majority of these models  
are organotypic, i.e., they aim to reproduce major functions of an organ or organ system. This implies in 
many cases that more than one cell type forms the 3D structure, and often matrix elements play  
an important role. This review summarizes the state of the art concerning commonalities of the different 
models. For instance, the theory of mass transport/metabolite exchange in 3D systems and the special 
analytical requirements for test endpoints in organotypic cultures are discussed in detail. In the next 
part, 3D model systems for selected organs – liver, lung, skin, brain – are presented and characterized 
in dedicated chapters. Also, 3D approaches to the modeling of tumors are presented and discussed. All 
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1  Introduction
1.1  Background
Specific tissue function and physiology may be lost in 2D sys-
tems. 3D culture models were created to better mimic the in vivo 
situation and to maintain such functions (Haycock, 2011). the 
currently available models are mainly specific for single organs 
and have been established to study the liver, nervous system, 
skin, respiratory system, intestine and the heart, among others. 
Such models are already in use in biomedical research. How-
ever, they have the potential to be useful also in toxicological 
testing schemes and for drug discovery. therefore, a workshop 
was organized by CAAt-europe and partners (Alexandra As-
sociation, BASF Se, Beiersdorf AG, eCOPA and l’Oréal) to 
assemble experts for 3D models of the liver, brain, lung and skin 
and for using their potential for toxicological testing. Future im-
provements to each system, design of potential new systems and 
hurdles to regulatory acceptance were discussed. From these 
experts, authors were selected to assemble the chapters of this 
review. Overall recommendations of the workshop participants 
are presented with the aim of improving the quality of organo-
typic models and facilitating their application in toxicological 
testing and drug discovery as a viable alternative to the current 
animal testing paradigm.
Differences in artificial organ design are a result of the desired 
endpoint: for instance, a model for skin irritation can potentially 
be achieved using a simpler strategy than, perhaps, the more 
complex endpoint of developmental delay of the formation of 
the nervous system. However, both endpoints are important in 
testing of drug candidates and chemicals. In this report, we try 
to outline the wide variety of approaches. We also exemplify 
the different levels of sophistication and the broad range of ap-
plications of 3D models, using four major organ systems as ex-
amples. 
1.2  Common themes
A most obvious common theme is cell choice and availability. 
Primary human cells can be difficult to come by, and they can be 
difficult to use in cell culture. Human stem cells and progenitor 
cells are an alternative option from the standpoint of sustain-
ability; however, differentiation to the correct cell type must 
be highly reproducible and standardized. It is also important to 
ensure that the cells perform as differentiated adult cells do in 
human organs. the use of tumor cell lines is easier, but genetic 
changes in tumor cells may confound the results. Use of ani-
mal cells may appear like a step backwards, but they offer clear 
advantages in some cases, and they may allow investigation of 
species differences, and also allow some form of validation of 
3D models in relation to the in vivo situation.
When discussing the transition from animal models to in vitro 
models, it is important to remember that test systems need not 
recapitulate every aspect of an animal model (or human disease), 
but they should provide predictive data for a particular question.
Another common theme is linked to technical limitations of 
model construction: at present, few models, such as the MCtS 
(multicellular tumour spheroids), have the potential to be pro-
duced at a large scale according to stringent standards required 
for toxicity testing and drug development. Mass production po-
tential may be key for application of 3D cultures in safety test-
ing and chemical and drug screening. Models requiring physical 
movement, e.g., lung models, may be more difficult to mass 
produce.
For each of the models, no matter how complex or simple, 
nutritional support, mass transport and monitoring (preferably 
online) are necessary (Fig. 1). In organotypic models, these all 
may become more complex. this important theme is therefore 
covered in a dedicated chapter on mass transport.
1.3  Mass transport
A basic requirement for the viability and functionality of a cell 
is continuous exchange (=bidirectional mass transport) with the 
adjacent environment. Cellular viability is maintained by a con-
tinuous supply of nutrients and oxygen as well as the removal 
of metabolic waste products (Hansmann et al., 2013). Addition-
ally, biological information is transmitted, e.g., via diffusible 
chapters give a historical background, illustrate the large variety of approaches, and highlight up- and 
downsides as well as specific requirements. Moreover, they refer to the application in disease modeling, 
drug discovery and safety assessment. Finally, consensus recommendations indicate a roadmap for  
the successful implementation of 3D models in routine screening. It is expected that the use of such models 
will accelerate progress by reducing error rates and wrong predictions from compound testing.
Keywords: organ-on-a-chip, organotypic, 3D models
Fig. 1: Microenvironmental factors affecting cell behavior 
Numerous aspects of the microenvironment that change spatially 
and temporally may affect how accurately a 3D model reflects 
cellular behavior in vivo. Conversely, cells (center) can actively 
modify their local microenvironment. Reprinted with permission 
from Yamada and Cukierman (2007).
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concentration of the diffusible molecule is determined by its rate 
of diffusion DA and its rate of disappearance kA.
With the situation depicted in Figure 2, the initial and boundary 
conditions are:
the stirred cell culture medium provides a constant concentra-
tion CA0 at the cell culture medium/biological tissue interface. 
From this interface, substance A diffuses into the tissue and is 
eliminated equally throughout the construct. With the initial and 
boundary conditions, the steady-state solution of equation 1 be-
comes:
 
the parameters for the concentration gradient shown in Figure 1 
are a diffusion rate of 1*10-11 m2/s and a half-life of 1 h. 
From the interface, substance A is distributed via diffusion 
and eliminated throughout the biological tissue. the steady-state 
distribution of the concentration shows a strong decay along the 
distance from the source into the tissue.
Both parameters are within a realistic range for proteins (Col-
ton et al., 1970). the diffusion-consumption model reveals a 
strong decay of the concentration with increasing distance from 
the cell culture medium/tissue interface and implicates areas de-
void of substance A. When A is a secreted messenger molecule, 
the signaling range xr can be estimated when a threshold cmin in 
percent for its minimal required concentration is given:
this simple mathematical model provides a basic approach to 
describe necrotic cores in spheroids or the formation of niches 
(Saltzman, 2004).
When comparing mass transport in 2D and 3D cell culture en-
vironments, nutrients are provided homogenously to the cells in 
a 2D cell culture system. However, communication of a cell with 
cells outside of its neighborhood via soluble factors is restricted 
to diffusion in the liquid phase. the supernatant represents a 
reservoir for the accumulation of secreted messenger molecules 
(Fig. 3A). the concentration distribution is determined by 
the local secretion qS and local incorporation rate qI  as well 
as the diffusivity DA of the messenger. Figure 3B depicts the 
distribution of a messenger molecule according to Figure 3A 
after 10 h. A protein is secreted with the secretion rate 
qS=1.78*10-16 mol/(s x m2), distributed with a diffusion rate of 
1*10-11 m2/s and eliminated with qI=1.78*10-16 mol/(s x m2). 
the overall height and length of the supernatant is 0.5 mm and 
boundaries have no flux conditions; except at the x-axis where 
regions with secretion or elimination are highlighted. Basically, 
gradient formation along the cell layer is possible. However, the 
majority of the secreted factors diffuses into the supernatant and 
substances. Spatial gradients and defined temporal changes re-
sult in patterns of signals and metabolites, which are essential 
for tissue development and maintenance (Fuchs et al., 2004; 
Votteler et al., 2010).
In vivo, physiological mass transport is maintained by active 
and passive processes on different scales (Aird, 2012; Pavel-
ka and Roth, 2005). Systemically, macroscopic blood vessels 
transport oxygen, nutrients, hormones, carbon dioxide and cat-
abolites. On a microscopic scale, in the capillaries, the mass 
exchange with the tissue is ensured across the endothelial cell 
layer. the endothelial layer can be fenestrated with pores to al-
low transit of large protein complexes (e.g., in the liver) or it 
can be very tight even to small molecules (e.g., in the blood-
brain barrier). For a modulated mass exchange across the cellu-
lar layer, different access routes are available, such as transport 
that is mediated by membrane proteins or receptors (lum and 
Malik, 1994). In the tissue, a variety of biological and physical 
mechanisms contribute to the spatial distribution of the mol-
ecule (Datta, 2002). For instance, cells incorporate, metabolize 
or synthesize and secrete molecules. Additionally, a directed 
mass flux can be established by tissue-specific cell types (Pusch 
et al., 2011). In the cellular interspace, concentration gradients 
result in diffusion. Furthermore, molecules can be captured at 
binding sites of the extracellular matrix (Ruhrberg et al., 2002). 
Depending on the complexity of an in vitro construct, such as 
scaffold material composition or seeded cell type, the specific 
transport mechanisms can significantly determine tissue devel-
opment (Hansmann et al., 2013).
Monitoring and analyzing the distribution of substances in a 
biological tissue is challenging (langer and Muller, 2004). Al-
ternatively, the chemical micro- and macro- environment in a 
tissue can be studied by computational modeling (Kalig et al., 
2013; Kirouac et al., 2010). However, the validity of a math-
ematical model depends on the availability of input parameters. 
A simple mathematical model to predict the spatial and tempo-
ral concentration cA(x,t) of a substance A in a local environment 
is the diffusion equation. Consumption of the species can be 
introduced by a consumption term (Saltzman, 2004). the local 
Fig. 2: Schematic representation of the situation at the 
cell culture media/biological tissue interface of a tissue 
engineering construct 
From the interface, substance A is distributed via diffusion and 
eliminated throughout the biological tissue. 
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of perfusable channels. Alternatively, vascularized tissues/scaf-
folds can be generated by de-cellularization of xenogeneic tis-
sues. In these biological scaffolds the structures of the former 
vascular system are still present and can be connected to fluidic 
systems (Scheller et al., 2013).
2  3D models of the liver
The liver plays a central role in detoxification processes, metab-
olism of carbohydrates, lipids and proteins as well as biotrans-
formation of endogenous and exogenous substances. the main 
biotransformation processes, catalyzed by cytochrome P450 
(CYP), take place in the liver tissue (Brandon et al., 2003; Coon 
et al., 1992; Hewitt et al., 2001). liver functionality is tightly 
linked to the assembly of specialized cell types, the majority of 
which are hepatocytes, embedded in a complex 3-dimensional 
structure made up of so-called lobules. liver lobules are the 
smallest functional units of the liver. the hepatocytes are polar-
ized and at their apical domains form an interconnected tubular 
structure, the bile canaliculi, which are the smallest branches 
of the biliary tree. the basolateral-apical polarization of the 
hepatocytes is essential to maintain the directed uptake and ef-
flux of endogenous and exogenous substances, determining the 
metabolic capacity of the hepatocyte. Often drug-induced hepa-
totoxic effects result from long-term exposure. Biotransforma-
tion of compounds usually results in non-toxic and more soluble 
metabolites, however, occasionally, more toxic metabolites may 
be formed causing hepatotoxicity (e.g., paracetamol overdose 
toxicity; James et al., 2003). Hepatocytes require their 3-dimen-
sional polarized structure to maintain liver-specific functionality. 
Therefore, cell culture technologies that maintain liver-specific 
metabolism and functionality over the long-term are necessary 
to allow chronic liver toxicity testing on human hepatocytes. Ac-
cordingly, the in vitro organotypic models of liver should allow 
does not contribute to cellular communication. Additionally, the 
average level of the signaling factor can be increased over time 
and, thus, the formation of niches with cells that are not activat-
ed by the messenger is blocked. Moreover, when the cell culture 
medium is mixed, e.g., by stirring or convection, homogeneous 
concentrations of the messenger molecule are established. thus, 
spatial and temporal information is lost.
Nutrient supply is usually limiting in dense 3D multi-cellular 
constructs that show an increased need of nutrients and oxygen 
due to high cell numbers per volume. to ensure the maintenance 
of mass transport, the distance between a cell and a capillary 
vessel usually is no further than 200 µm in vivo (Novosel et al., 
2011).When a region becomes supplied insufficiently, new ves-
sels grow into the area by angiogenesis (Carmeliet, 2005). this 
process is controlled by a not yet fully understood spatial and 
temporal pattern of diffusible growth factors such as vascular 
endothelial growth factor (VeGF) and platelet-derived endothe-
lial growth factor (PDeGF). In vivo, endothelial cells are re-
sponsive to these cues and begin to sprout into the area with low 
supply. In vitro, endothelial cells are also able to form vessel-
like structures if seeded into 3D scaffolds such as Matrigel™ 
and collagen hydrogels (Donovan et al., 2001). However, no 
fully functional microcirculation system has been recreated, yet. 
A reason for the poor outcome is that the vessel-like structures 
are not perfused and, thus, the endothelial cells are cultured 
without shear stress, which is known to be a vital stimulus for 
the function of endothelial cells (Chien, 2007). In alternative 
approaches, endothelial cells are seeded into tubular structures, 
which are embedded in various scaffolds. these tubular struc-
tures can be connected to a fluidic system to generate a constant 
or pulsatile medium flow. The simplest method is to embed a 
needle into a hydrogel during gelation (Chrobak et al., 2006). 
More sophisticated systems use sugar derivatives to generate 
complex structures (Miller et al., 2012). the sugar can then be 
dissolved, which results in a branched interconnected system 
Fig. 3: Cellular cross talk via soluble factors in a 2D system 
(A) Cells in a monolayer secrete and internalize signaling factor. The messenger is distributed in the supernatant. (B) Simulated 
distribution of the concentration of a signaling molecule in the supernatant. The molecule is secreted and eliminated along the x-axis by 
the cells. qS indicates secretion, qI internalization. The formation of a gradient at the cell/supernatant interface is possible.
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albumin and loss of CYP expression, than hepatocytes in 3D 
systems. 
Compared to the conventional maintenance in 2D culture 
methods, the three-dimensional cultivation of hepatic cells 
using extracellular matrix scaffolds or microcarriers, or the 
hollow-fibre based perfused 3D four-compartment bioreactor, 
offers improved conditions for long-term preservation of cell 
integrity and functionality by supporting cell-cell contacts and 
signal exchange. It has been shown that 3D-culture enables 
prolonged cultivation of primary human hepatocytes, which 
in turn allows longer-term (greater than 3 week) studies to be 
performed. Cultivation in a perfused bioreactor provides a con-
tinuous mass exchange of culture media and decentralized con-
trolled oxygenation. the cells are supported by aggregation to 
other cells. this provides an excellent scaffold to maintain a 
physiological environment for in vitro cultures allowing inter-
cellular communication. 
2.2  Benefits and uses of 3D organotypic  
liver models
In vitro, the 3-dimensional structure of hepatocytes can be main-
tained by controlling the physical interactions between the cells. 
the current gold standard to maintain hepatocyte polarization and 
functionality is the sandwich culture, in which cells are grown 
in between two layers of extracellular matrix constituents such 
measurement of various endpoints of physiological relevance in 
order to mimic the situation in the liver in vivo. Figure 4 shows 
some exemplary 3D liver cell cultivation techniques. 
2.1  Cell sources for in vitro liver models
In vitro liver models include various methods of using the liver 
cells in basic research as well as in toxicity screenings. the 
source of the cells and the cultivation techniques are determin-
ing factors in the application of these in vitro liver models.
traditionally, mammalian liver cells (e.g., primary rodent or 
porcine hepatocytes) are used in biotransformation and toxicity 
screenings. However, species-specific differences in xenobiotic 
metabolism necessitate the use of human hepatocytes in pre-
clinical pharmaceutical development (Hewitt et al., 2001; lauer 
et al., 2009; Uehara et al., 2008). In particular, human cells most 
faithfully replicate actual human pharmaco- (and toxico-) kinet-
ics and drug (chemical) metabolism. However, current methods 
mainly use either fractions of cells or non-adherent hepatocytes 
in short-term studies: Cultured primary human hepatocytes can 
provide the whole range of liver-specific metabolism, includ-
ing transporter proteins and human-relevant CYPs. However, 
simple 2D culture methods have been shown to quickly lose 
functionality. Comparative studies with primary human hepato-
cytes in 2D show a faster decrease of cells with the differenti-
ated hepatic phenotype, leading to lower production of urea and 
Fig. 4: 3D liver cell cultivation techniques 
(A) Polarized hepatocytes in collagen sandwich cultures (reprinted with permission from Tuschl, 2009). (B) 3D membrane bioreactors with 
perfusion system (reprinted with permission from Zeilinger et al., 2011). (C) Stirrer bioreactor for 3D aggregates (reprinted with permission 
from Tostoes et al., 2012). (D) Hanging drop liver organoids (reprinted with permission from Mueller et al., 2013). (E) 3D polystyrene 
scaffold culture (sc-scaffold, grey arrow indicates microvilli) (reprinted with permission from Bokhari, 2007). (F) A microfluidic device 
ensuring perfusion in multi-well plate format (reprinted with permission from Domansky, 2010). 
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biological question and the endpoint of the assay as well as on 
the number of data points required (fit for purpose principle).
2.4  Technologies used to generate 3D  
organotypic liver models 
Current methods mainly use either fractions of cells or non-ad-
herent hepatocytes in short-term studies. Cultured primary hu-
man hepatocytes can provide the whole range of liver-specific 
metabolism, including transporter proteins and human-relevant 
CYPs. However, hepatocytes maintained in simple 2D culture 
have been shown to dedifferentiate and rapidly lose functional-
ity (Godoy et al., 2009; Gomez-lechon et al., 1998). Compared 
to the conventional maintenance in 2D culture systems, the 
three-dimensional cultivation of hepatic cells offers improved 
conditions for long-term preservation of cell integrity and func-
tionality by supporting cell-cell contacts and signal exchange. 
Various methods of 3D cultivation have been reported using 
extracellular matrix scaffolds (Dunn et al., 1989; Marion et al., 
2007), microcarriers (Miranda et al., 2009; Ringel et al., 2005) 
or the hollow-fibre based perfused 3D four-compartment biore-
actor (Gerlach et al., 2003) to name a few. Primary human hepa-
tocytes cultured in 3D bioreactors showed a better maintenance 
of the differentiated hepatic phenotype, along with a higher 
stability of urea and albumin production and CYP expression, 
as compared with conventional 2D cultures (Hoffmann et al., 
2012). An excellent review on advances in 2D and 3D liver sys-
tems has been recently published (Godoy et al., 2013).
Collagen-sandwich cultures 
the simplest “quasi 3D” system to maintain hepatocyte polari-
zation and functionality is the sandwich culture, in which cells 
are grown in between two layers of extracellular matrix con-
stituents such as collagen (Marion et al., 2007) or Matrigel™ 
(Ogimura et al., 2011). Collagen sandwich cultures have been 
in use since more than two decades, have been shown to main-
tain differentiated hepatic phenotype (Dunn et al., 1991) and 
have been applied in toxicity and drug-drug interaction studies 
(tuschl et al., 2009). PHH in sandwich cultures show compa-
rable transporter expression to human liver tissue (Schaefer et 
al., 2012). Sandwich cultures do show differences as compared 
to 3D culture and in vivo liver (lu et al., 2012b). Other similar 
cultures with embedded hepatocytes, including the hydrogels 
such as Matrigel™, collagen, gelatine and peptide hydrogels, 
have been reported (see review by Godoy et al., 2013).
3D bioreactors
3D liver bioreactors were initially developed for clinical use as 
bioartificial liver (BAL). Many such devices for in vitro applica-
tions have been reported (Mueller et al., 2011b; Darnell et al., 
2011; Hoekstra et al., 2011; tostoes et al., 2012; Zeilinger et al., 
2011). Cultivation in a perfused bioreactor provides a continuous 
mass exchange of culture media and decentralized controlled ox-
ygenation. the cells are supported by aggregation to other cells. 
this provides an excellent scaffold to maintain a physiological 
environment for in vitro cultures allowing intercellular commu-
nication. It has been shown that 3D-culture enables prolonged 
cultivation of primary human hepatocytes, which in turn allows 
as collagen. Other approaches to coax hepatocytes into the third 
dimension make use of either solid scaffold materials such as 
polystyrene scaffolds or de-cellularized tissues, hydrogels such 
as collagen type-I or alginate embedding, or self-assembling of 
hepatocytes into spheroids. In the majority of the 3D cell culture 
approaches, improved liver specific functionality and metabo-
lism over longer time periods is achieved as compared to clas-
sical monolayer cultures. In order to further improve exchange 
of nutrients, oxygenation and waste removal perfused bioreactor 
systems are being developed to grow hepatocytes. 
2.3  Disadvantages of 3D organotypic  
liver models
the cell source plays a pivotal role for the predictive power of 
in vitro liver models. the decision whether to use primary cell 
sources or cell lines, single type models or co-cultures depends 
strongly on the purpose and the end point of the assay as well as 
the number of data points required. Due to species-specific di-
vergences of the xenobiotic metabolism, primary human hepa-
tocytes are considered as gold standard. Genetic and metabolic 
variations of the donors impact the response towards substances, 
representing the diversity of the human population. However, 
the availability and lifetime of freshly isolated primary human 
hepatocytes (PHH) is limited. Recently, it was reported that use 
of suitable cultivation medium ensures long-term viability and 
functionality of PHH for application in chronic toxicity studies 
(Mueller et al., 2012). Human liver cell lines such as HepG2 
and Hep2/C3A have been used for a long time in toxicological 
profiling. However, many of these cell lines show only poor, or 
fractional, hepatic enzyme expression. Also, normal energy me-
tabolism can be largely different from that of primary cells (latta 
et al., 2000). this limits the use of these cell lines in metabolism 
mediated toxicity studies. However, the HepG2 cell line has 
been used in studies for parent compound toxicity, cell polarity 
or chemotherapy resistance (Hoekstra et al., 1999; Mueller et 
al., 2011a; Noor et al., 2009; O’Brien et al., 2006). A promising 
cell source is represented by the HepaRG cell line, which shows 
a high comparability to primary human liver cells regarding 
metabolic activities (Andersson et al., 2012; Guillouzo et al., 
2007; Kanebratt and Andersson, 2008; lubberstedt et al., 2011). 
Nevertheless, a recent publication demonstrated that in contrast 
to primary hepatocytes the sensitivity of cell line-based mod-
els to detect substance toxicity is below that of primary human 
hepatocytes (Gerets et al., 2012). Another promising source of 
human hepatocytes can be seen in human embryonic stem cell 
(heSC) derived hepatocytes (Mandenius et al., 2011). However, 
ethical issues with the use of heSC derived cells limit their gen-
eral acceptance. Next generation cell sources for developing in 
vitro liver toxicity models will be derived from induced pluripo-
tent stem cells (iPSC) (Shtrichman et al., 2013). Since iPSC are 
generated by reprogramming of cells from adult tissue, they can 
be derived from multiple individuals and thus allow covering 
diverse genetic backgrounds. Moreover, due to their expansion 
capacity they allow performing repeated experiments using the 
same cell line over time.
the decision whether to use primary cell sources, cell lines 
and single type or co-culture models depends strongly on the 
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the liver spheroids formed in stirrer bioreactors have been 
proposed to be suitable for toxicity studies (leite et al., 2012; 
Miranda et al., 2010; tostoes et al., 2011). the hanging drop 
liver spheroids have been extensively characterised for liver 
specific functions (Michailov et al., 2004) and applied in the 
assessment of toxicity (Gunness et al., 2013). these spheroid 
cultures have also been applied for screening of a number of 
hepatotoxic drugs and in the repeated dose toxicity of chlorpro-
mazine (Mueller et al., 2013b).
2.7  Drug metabolism and pharmacokinetics
Predicting in vivo hepatic clearance using in vitro metabolism 
assays is an inherent part in drug development to determine 
half-life, bioavailability, dose and dosing regimens (Obach, 
2011). especially challenging are low-clearance compounds, 
which are becoming more and more important in drug devel-
opment (Di et al., 2012). Current gold standard models such 
as human liver microsomes and suspension culture of human 
hepatocytes usually have a too short assay window leading to 
imprecisions in the prediction of human clearance, half-life and 
dose. Due to improved long-term metabolic competence of the 
3D organotypic hepatic cultures, these can be applied in drug 
metabolism and pharmacokinetic studies, especially to deter-
mine the metabolic profile of low-clearance compounds (Butler 
et al., 2013; Darnell et al., 2011; Nyberg et al., 1994; Zeilinger 
et al., 2002). 
2.8  Limitations of 3D organotypic liver models
Although 3D organotypic liver cultures show definite advan-
tages in long-term maintenance of hepatic functions, depending 
on the system there are limitations to their universal application 
as with any other system. there are several technical challenges 
in addition to limitations in applications. For example, the per-
fused 3D bioreactors provide the option for long-term studies in 
a serum-free culture environment. they have been miniaturized 
(Zeilinger et al., 2011) and even allow for kinetic biochemical 
assays (Mueller et al., 2013b). Nevertheless, current 3D biore-
actor systems for the liver are, from a model perspective, quite 
large, and since the reorganization of the cells requires a criti-
cal cell mass, the extent of miniaturization is limited. As such, 
application in high throughput platforms is very limited. the 
requirement of high cell numbers also limits the number of par-
allel bioreactors from the same donor in case of PHH. Another 
factor limiting miniaturization possibilities is the clear necessity 
of complex mass-transport to provide the appropriate nutrients 
and remove waste at the appropriate time. this is a common 
problem in 3D models and will be discussed in more detail in a 
later section. Most of the perfused bioreactor systems are closed 
systems and therefore allow only endpoint sampling of the tis-
sue material, e.g., for immunohistological investigations. this 
also means that the injected cell mass needs a minimum quality 
since dead cells are also injected into the system and cannot be 
removed. the binding of lipophilic drugs is another problem. 
the various perfused bioreactor systems require technical ex-
pertise and experience.
2D models can be easily adapted to metabolomics and flux 
analyses (Klein et al., 2013; Niklas et al., 2009; Strigun et al., 
longer-term (>3 weeks) studies to be performed (Zeilinger et al., 
2011). A major advantage of this system with respect to its use in 
pre-clinical toxicity assays is that it allows for cultivation under 
serum-free conditions (lubberstedt et al., 2012). 
In addition, in these hollow-fibre bioreactors, the differentia-
tion of human embryonic stem cells towards hepatic cells as a 
potential alternative cell source for studies on hepatic cells is 
demonstrated by a significant up-regulation of genes related to 
liver functions (Miki et al., 2011) and enhanced hepatic differ-
entiation in the 3D four-compartment bioreactor system com-
pared to conventional 2D cultures (Sivertsson et al., 2013). 
Multicellular spheroid cultures
3D multicellular liver spheroids can be produced in scaffold 
free systems in multiwell plates by the self-assembling of 
hepatocytes into aggregates (Brophy et al., 2009; Kelm and 
Fussenegger, 2004; Kelm et al., 2003) or in stirrer bioreactors 
(Miranda et al., 2009). Hepatic spheroids form liver like struc-
tures within and are viable for long periods of time exhibiting 
good functionality. these are well suited for high throughput 
applications. the size of the spheroids is a critical parameter 
as large spheroids may result in oxygen and nutrient limitation 
in the centre leading to necrotic cores (lin and Chang, 2008) 
or in stirrer bioreactors (Brophy et al., 2009; Kelm and Fuss-
enegger, 2004; Kelm et al., 2003). Hepatic spheroids form liver 
like structures within and are viable for long periods of time 
exhibiting good functionality. these are well suited for high 
throughput applications. the size of the spheroids is a critical 
parameter as large spheroids may result in oxygen and nutri-
ent limitation in the centre leading to necrotic cores (lin et al., 
2008; lin and Chang, 2008).
Other 3D cultivations
Other approaches to coax hepatocytes into the third dimension 
make use of either solid scaffold materials such as polystyrene 
scaffolds (Bokhari et al., 2007; Burkard et al., 2012; Schutte et 
al., 2011b) or de-cellularized tissues (linke et al., 2007). 
3D hepatic cultures also have been used in microfluidic de-
vices in multiwell or chip based systems for controlled medium 
flow and microenvironment (Domansky et al., 2010; Powers et 
al., 2002; Schutte et al., 2011a). Co-culture of hepatic spheroids 
with endothelial cells has been reported (Schimek et al., 2013). 
A recent review discusses the application of microfluidic de-
vices especially in multiorgan systems (Materne et al., 2013). 
2.5  Applications of 3D organotypic liver models
two recently published reviews summarize the applications of 
3D liver models (Godoy et al., 2013; Mueller et al., 2013a). 3D 
liver models can be applied in toxicological screenings as well 
as in the studies of drug metabolism and pharmacokinetics as 
discussed below.
2.6  Toxicology research
Due to prolonged viability and functionality the 3D liver mod-
els have great potential in toxicological research especially for 
long-term studies. Both bioreactors and spheroid cultures have 
been used in toxicity applications. 
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biology in vitro. In addition, 3D organotypic liver cultures will 
allow better in vitro to in vivo extrapolation of pharmacokinet-
ics of drug/compounds. It is expected that the 3D organotypic 
liver models will greatly improve the prediction of effects and 
bioavailability. Another exciting future direction is the use of 
3D liver cultures in multi-organ chips in a “body-on-a-chip” 
approach. 3D organotypic liver cultures will also be valuable 
in mechanistic studies for DIlI (drug induced liver injury) and 
may one day allow completely replacing of the use of animals 
for specific testing purposes. 
3  3D models of the nervous system
In vitro models have contributed a lot to the elucidation of the 
modes of action of neurotoxicants. Moreover, they have been 
useful to establish rank orders of potency of various compounds, 
once their mechanism has been understood. In contrast to this, 
cell culture-based predictions of neurotoxicity, starting without 
prior knowledge, have been difficult. This is in part due to the 
vast complexity of the nervous system, in particular the brain, 
spinal cord and peripheral nervous system, and to the associated 
large number of molecular targets and possible pathways of tox-
icity that may become relevant. the use of more complex mod-
els may improve this situation, as their underlying basic bio-
logical functions may be used as readouts, without necessitating 
exact knowledge of the upstream modes of action of potential 
toxicants. 3D models are expected to contribute to this progress 
by allowing the modelling of more biological processes that are 
essential for the functioning of the brain and nervous systems. 
3.1  What are the key issues to be modelled  
by 3D nervous system models? 
three fundamentally different aspects are important for the mod-
els: 1) cell type and composition; 2) maturity of the cells and 
3) structural organization of cells and their matrix. “Cell type 
and composition” refers to the fact that neural tissues are com-
posed of many subtypes of neurons and also different types of 
glial cells. the latter comprise the large, and sometimes hetero-
geneous, groups of astrocytes, oligodendrocytes, Schwann cells 
and microglial cells. Multicellular units are fundamental for the 
performance of the nervous system and for many underlying 
biological processes such as synapse formation and function. 
the presence of glial cells is of utmost importance since they 
can be both targets and mediators of chemically induced brain 
injury. Moreover, the presence of glia may affect or modulate 
the toxicity of chemicals for neurons (e.g., eskes et al., 2003; 
Giordano et al., 2009; Kuegler et al., 2012, 2010; Schildknecht 
et al., 2009; Viviani et al., 1998; Zurich et al., 2004, 2002, 1998), 
or they may be drivers of neuro-inflammation (e.g., Boillee et al., 
2006a,b; Falsig et al., 2004, 2008; Henn et al., 2011, 2009; Hoing 
et al., 2012; Monnet-tschudi et al., 2007). the proportion of the 
different types of glial cells is also an important factor since it 
modulates the release of bioactive molecules upon toxic exposure 
(eskes et al., 2002; Simon et al., 2002). Glial cells can also deter-
mine the reaction of the overall tissue to injury, as they take over 
the role of phagocytosis of dying neurons and neurite debris (Hirt 
2011a,b, 2012). Although some 3D models can be very well 
adapted to “-omics” application, most of these have their own 
advantages and disadvantages. In case of 3D hollow fibre bio-
reactors, large perfusion volumes limit the use of expensive 13C 
substrates for flux analysis. As for the 3D spheroids, there are 
many advantages. However, in this case very low volumes make 
the various analyses, such as transcriptomics and proteomics, 
difficult. In addition, the readouts are from a few thousand cells 
and therefore the analysis methods have to be optimized for sen-
sitivity. 
2.9  Challenges and future focus of 3D liver models
evaluating liver toxicity is crucial in the assessment of the 
safety of drugs, chemical substances, nutritional supplements 
and cosmetics. Current state-of-the-art in vitro and in vivo tech-
nologies have shown limitations in accurately predicting human 
hepatotoxicity. Next generation in vitro liver models will have 
to reflect the liver architecture and cell composition more close-
ly to allow for more precise toxicological profiling.
Complexity of liver (non-parenchymal cells)
liver is a very complex organ and includes in addition to hepa-
tocytes (80%) various non-parenchymal cells (endothelial, stel-
late and Kupffer cells). It is known that the non-parenchymal 
cells (NPCs) also play a role in hepatotoxicity. Various 3D co-
cultures of hepatocytes with NPCs have been reported, e.g., 
models for vascularized liver (Inamori et al., 2009) with co-cul-
tured spheroids or in-chip based systems (Messner et al., 2013; 
Powers et al., 2002). However, this area needs further develop-
ment for toxicological purposes, e.g., in case of immunity medi-
ated toxicity and other pathophysiology such as fibrosis. 
Complexity of liver (zonation)
Since the liver performs a wide range of diverse functions, the 
hepatocytes show a large heterogeneity and plasticity of func-
tions. this is referred to as metabolic zonation in the liver (Ge-
bhardt and Jonitza, 1991; Jungermann and Kietzmann, 1996). 
In case of isolated hepatocytes the zonation is lost and it would 
be of tremendous interest if this zonation can be restored in any 
of the 3D cultures. this will pave the way to use in vitro 3D 
organotypic liver models to study in vivo liver functions such as 
lipid and bile acid metabolism as well as glucose homeostasis. 
However, in case of toxicity studies, this may not be a critical 
point as all isolated hepatocytes may be synchronized by induc-
tion of drug metabolizing enzymes and transporters.
2.10  Implications of use of 3D liver models  
for the future
3D organotypic liver models exist for more than two decades. 
However, the paradigm of drug testing is only now moving from 
2D cultures to 3D liver cultures with advances in technology. 
this has become possible with better accessibility to techniques 
of 3D cultivation and at the same time technological progress 
with respect to miniaturization and modern perfusion systems, 
allowing the idea of “liver on a chip” to become a reality. For 
specific purposes 2D cultivation may still be suitable. However, 
3D organotypic cultivation must lead to in vivo relevant systems 
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et al., 2012). the exposure of the developing brain to chemicals 
would be modified by the placental barrier, which also requires 
modeling for predictions from in vitro models to man (Giordano 
et al., 2009). Figure 5 shows schematic representation of 3D in 
vitro models of the nervous system.
At the intersection of structural organization and cell com-
position, there is another important aspect of 3D models: the 
formation of highly specific cell biological niches in the devel-
oping and developed brain. Such niches are formed by specific 
cell compositions and gradients of signalling molecules, and 
they provide a highly defined environment (e.g., enriched or de-
prived of certain signalling molecules) for the development and 
function of cells. Specialized glial cells are often important for 
such niches and are therefore required for modelling them. ex-
amples are, e.g., the neurogenic niche of the adult brain, differ-
ent complex niches in the retina, or the niche formed by satellite 
glial cells and pain neuron somata in trigeminal ganglia (Jasmin 
et al., 2010). Gradients of signalling molecules and niches are 
particularly important during development for the guidance of 
cell migration, for cell differentiation and thus for the overall 
patterning of the brain. 3D test systems have obvious advan-
tages over 2D cultures when the modeling of niches is a major 
objective of the experiments. For instance, the combination of 
the intrinsic characteristics of stem cells and their microenvi-
ronment facilitates self-renewal and symmetric division, while 
differentiation occurs by asymmetric cell division (Fuchs et al., 
2004; Morrison and Spradling, 2008).
et al., 2000; Hirt and leist, 2003). therefore, the inclusion of the 
different types of glial cells is an important consideration for the 
setup of a neural 3D model. In the same vein, it may be consid-
ered to combine different types of neurons, or different types of 
glia, to cover all processes affected by toxicants. For modelling 
of neuroinflammation even inclusion of, e.g., lymphocytes may 
be required, as they modulate many brain processes (Kipnis and 
Schwartz, 2005) and extreme synergy can be generated between 
macrophages and lymphocytes (Gantner et al., 1996).
the “structural organization” affects the connectivity of the 
cells, the networks they may form, and the signals they can ex-
change. this has immediate secondary effects, e.g., on the activ-
ity of cells, on their metabolism or on their control of specific 
differentiation processes (e.g., myelin formation by oligodendro-
cytes or Schwann cells wrapping around neurites). Several meta-
bolic pathways in the brain run across different cell types, e.g., 
astrocytes take up glutamate, transform it to glutamine and feed 
this to neurons, or they provide neurons with specific energy sub-
strates or essential thiols. A particular example of a 3D structure 
formed by several cell types is the blood-brain barrier, and an 
understanding of its function has a profound importance for the 
prediction of neurotoxicity. In an adult organism, the blood-brain 
barrier has a large influence on the exposure of brain cells. In-
formation on the concentration of compounds reaching the brain 
(or the target cell in 3D organotypic cultures) has to be derived 
from in vitro or in silico models for the blood-brain barrier. Dif-
ferent 3D models have been established in this area (Vandenhaute 
Fig. 5: Schematic representation of 3D in vitro models of the nervous system
The first 3D in vitro models used rodent acute or organotypic brain slices. These are still a major model for electrophysiological studies 
(A). Alternative approaches use co-culture models consisting of, e.g., a layer of neurons directly on top of a glial cell layer (B). Transwell 
culture models are used, e.g., for in vitro blood-brain barrier models by growing endothelial cells on a perforated membrane above a glial 
cell layer. Neurons may be attached to the bottom compartment (C). Re-aggregating brain cell culture models are formed by spontaneous 
re-aggregation of dissociated rodent brain cells under continuous shaking (D). Floating neurospheres can be generated from neural 
stem cells/neural progenitor cells, kept in low adherence plastic plates (E). Secondary 3D cultures are produced by plating neurospheres 
onto a planar adhesive substrate, which facilitates outgrowth of radial glia and migrating neurons (F). Engineered neural tissue (ENT) is 
generated by growing highly concentrated suspensions of stem cells on a membrane floating at the air-liquid interphase. This tissue is 
polarized (e.g., astrocytes at the bottom), consists of several subtypes of neurons and shows rosettes as neural tube-like structures (G). 
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nectivity may be more important than the three-dimensionality 
as such. this situation is different from several other organs. For 
instance, the liver has a highly repetitive structural organization, 
in which one given unit (liver lobule or liver acinus) has the 
same function as any other of these basic units. the situation is 
more complex in lungs and kidneys but, also there, a multitude 
of exchangeable functional units can be found across the entire 
organ (terminal broncheoli in lung, nephrons in kidney). this is 
not the case in the brain. It may rather be compared to a complex 
integrated circuit. the exact connections between the elements 
are important, not their three-dimensionality as such. In fact, 
examples from microelectronics show that two dimensions with 
a minimal extent of a third dimension are perfectly sufficient to 
model most complex neuronal networks. the generation of such 
structured neuronal networks from stem cells using, e.g., cell 
3D printing, sophisticated 3D matrixes or optimized differentia-
tion protocols is just about to start, and such technologies may 
revolutionize the future.
Similar to neurons as a whole, also their neurite structures are 
organized in highly specific ways. For instance, they are organ-
ized within a nerve, and there are pronounced differences be-
tween dendrites and axons (Kim et al., 2007; lein et al., 2007). 
Specific 3D models will eventually need to take this into account. 
the organization of the peripheral nervous system requires long 
neurites that emerge, e.g., from ganglia situated close to the spi-
nal cord. the somata of the respective neurons are closely as-
sociated with glia in specific 3D structures. Myelin formation in 
the peripheral nervous system is a typical process that requires 
defined cell-cell interactions, for example, receptors expressed 
on neuronal and Schwann cells membranes (e.g., neuregulin-1 
and Neecl4) are essential for forming mature myelin. 
the ratio between different cell types is an important issue 
but, in the brain, it is not only the average ratio but the many 
different local ratios that make the biological difference. Recon-
struction of such locally specialized cell units and of the associ-
ated niches is a formidable task.
the complexity of structure will need most likely to be re-
flected by specific functional endpoints. Optical or electronic 
measurements with simultaneously high temporal and spatial 
resolution will be required for many applications. tissue that 
is not organized in a point symmetric way will also need to be 
manipulated and fixed with a defined spatial orientation for such 
readouts.
3.3  Different types of technologies used to 
generate 3D nervous system models
Several technologies have been established to generate 3D 
cultures and co-cultures employing different cell populations. 
the approaches may be categorized according to complexity, 
cell types involved, source of cells, or their purpose, e.g., for 
DNt vs. Nt testing. One approach is layering, e.g., neurons 
on top of glia, to allow formation of neuronal-glial functional 
units (Schildknecht et al., 2012; Viviani, 2006). Such models 
have only a small extension in one (z) of the dimensions, but 
the layers may be analyzed separately, e.g., by the use of con-
focal microscopy. there are several variations of such models 
with only 2-5 cell layers in one dimension. For instance, DNt 
The final fundamental aspect to be considered is cell maturity. 
there is an important difference whether a model is established 
to predict toxicity to the adult, mature and relatively static nerv-
ous system, or whether the center of interest is disturbances of 
brain development. The first types of models are pertinent to 
neurotoxicity (Nt) and the second to developmental neurotox-
icity (DNt). DNt is a sub-discipline of toxicology that belongs 
to the larger field of developmental/reproductive toxicity, while 
Nt is usually considered in the context of systemic acute or 
chronic organ-specific toxicity. Thus, the models, and the ques-
tions to them, are largely different. Concerning maturity, the first 
question to be answered of any model is whether it addresses 
changing states of maturity (DNt models) or a stable state (Nt 
models). The second issue to be addressed is the definition of 
the initial maturity state of the cells, e.g., at the time when toxi-
cant exposure starts. For the definition of maturity and for the 
effects of toxicants, modern omics methods may deliver richer 
information than traditional single endpoints (Balmer et al., 
2012; Ramirez et al., 2013; Waldmann et al., 2014). this would 
also include information on the epigenetic state and changes of 
the cells (Balmer and leist, 2014).
3.2  Issues and future challenges to be addressed 
by 3D in vitro nervous system models
Nt and DNt are currently assessed for regulatory purposes by 
conventional in vivo methods that are regulated e.g., for chemi-
cals by OeCD guidelines (OeCD, 1997, 2007). these experi-
ments are time consuming and costly, and, for this reason, the 
tests are often not performed at all. therefore, many chemicals 
lack Nt/DNt information altogether. this has spurred the de-
mand for predictive toxicological in vitro methods to assess 
chemicals quicker and in a more economically feasible man-
ner (Bal-Price et al., 2010a). Several promising in vitro models 
have been developed for examination of either Nt or DNt (Bal-
Price et al., 2010a,b, 2012; Coecke et al., 2007; Honegger et 
al., 1979, 2011; Kadereit et al., 2012; Krause et al., 2013; Krug 
et al., 2013a,b; Kuegler et al., 2010; Stiegler et al., 2011; van 
thriel et al., 2012).
Many of them are based on 2D cell cultures. Such models 
have proven to be useful, e.g., for studying the molecular mech-
anisms of neuronal growth and survival (Gebhardt and Jonitza, 
1991; Stiegler et al., 2011; Volbracht et al., 2001, 1999). How-
ever, modeling the complexity of neurite networks and brain 
cell architecture in vitro is limited in 2D neural cell cultures. 
For example, glial cells have an important role during the cell 
migration process of brain development: guiding the neurons to 
the right position. Such processes cannot be mimicked in mono-
cultures. they require contribution of at least two cell types and 
they require a defined, often 3D, organization. Thus, it appears 
that 3D models have advantages for reproducing the complexity 
of directional growth and connections and of tissue structuring 
(limongi et al., 2013), and most likely many other processes 
specific for the nervous system.
the transition from 2D to 3D does not necessarily solve all 
predictivity issues of in vitro models and important challenges 
remain for the future: the brain has a complex, non-repetitive 
3D structure that determines its connectivity. The specific con-
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they are stirred (Honegger et al., 2011, 1979; Honegger and 
Richelson, 1976; Moscona, 1960, 1961). Such cultures allow 
for formation of histotypic structures, such as natural extracel-
lular matrix, mature synapses, functional neuronal networks and 
myelinated axons (Honegger et al., 2011). Re-aggregating brain 
cell cultures proved to be suitable for the detection of organ-
specific toxicity (Zurich et al., 2013) and have been used suc-
cessfully for Nt and DNt investigations.
Spheroids may also be formed by proliferation of neural pre-
cursor cells under conditions allowing all progeny of initially 
few cells to stick together. For instance, culturing coarse human 
or rodent brain cell homogenates (containing individual cells) in 
the presence of growth factors (Chiasson et al., 1999; Kuhn and 
Svendsen, 1999) eliminates most cell types originally present 
in the tissue and allows the few stem cells to proliferate and 
form neurospheres. NSCs and neural progenitor cells grown in 
suspension are responsive to mitogenic factors such as FGF-
2 and eGF. these maintain cell proliferation and promote for-
mation of sphere-like aggregates (neurospheres) (Reynolds et 
al., 1992; Singec et al., 2006). Neurospheres have the ability to 
produce their own extracellular matrix molecules (fibronectins, 
laminins), β-integrins and growth factors (Campos et al., 2004; 
lobo et al., 2003). the cellular milieu of the neurosphere has 
been suggested to exhibit an in vitro microenvironment similar 
to the in vivo compartment (Conti and Cattaneo, 2010). this 
may allow generation of physiologically relevant cellular sys-
tems in drug discovery and toxicology screenings. In addition, 
since neurospheres provide a microenvironment for key events 
during neurodevelopment such as NSC maintenance, prolifera-
tion and differentiation, the neurosphere system enables the as-
sessment of neurodevelopmental toxicants (Fritsche et al., 2011; 
Moors et al., 2009).
Secondary 3D cultures may be generated from neurospheres 
by plating them onto a planar substrate. they may then, e.g., be 
used for electrophysiological studies or to follow differentiation 
during radial migration on a laminin-coated surface (Moors et 
al., 2007, 2009; van Vliet et al., 2007). It is noteworthy that 
despite differentiation onto a surface, this manner of differentia-
tion differs from simple 2D single cell plating because there is 
glial cell guidance with neuronal growth on top in a process-
organized manner out of an organoid cell system (Ahlenius and 
Kokaia, 2010; Bal-Price et al., 2012; liu and Sun, 2011; Sch-
reiber et al., 2010). this phenomenon can be seen in the organ-
ized process of cell migration, which can also be quantified in 
such a system (Moors et al., 2007, 2009).
Generation of neural stem cells (NSC) from pluripotent 
stem cells is an alternative to the isolation of NSC from fetal 
brains. However, there are still some differences: so far only 
few groups could successfully expand NSC cultures for long 
periods of time (Koch et al., 2009; Palmer et al., 1997). When 
such cells are kept in 2D cultures, the gene expression level and 
cellular functionality often differs from original NSC or from 
cells growing in 3D (Birgersdotter et al., 2005; Kanebratt and 
Andersson, 2008; Zahir and Weaver, 2004). the expression pro-
file in 3D cell cultures appeared to be more similar to the gene 
expression levels in vivo than that of their 2D counterpart (Ab-
bott, 2003). thus, toxicological and pharmacological screenings 
models operating at the stage of neural tube induction often use 
very high cell densities that may form more than one cell layer. 
this partial extension into the third dimension is important for 
the generation of defined cell biological niches (Chambers et al., 
2012; Zimmer et al., 2012). Cells can also be layered on a per-
forated membrane. For instance, combinations of layered glial 
cells and endothelial cells may be used for blood-brain barrier 
models to measure drug transport. Also, strongly 3-dimensional 
complex blood-brain barrier models have been generated. these 
do not allow the study of drug transport, but may allow the ex-
amination of toxicant effects on the blood-brain barrier structure 
(Al Ahmad et al., 2011). A variant of the membrane technique 
is the formation of 3D tissue at an air liquid interphase (Dubois-
Dauphin et al., 2010; Preynat-Seauve et al., 2009). Alternative-
ly, cells may be grown in artificial scaffolds to promote three-
dimensionality (lu et al., 2012a). 
Novel 3D in vitro models are continuously emerging in 
parallel areas (e.g., regenerative medicine). therefore, not all 
technologies required for drug discovery 3D models need to be 
developed by toxicologists and pharmacologists. It is rather im-
portant to remain open to progress in other fields. For instance, 
research into the development of surgical biodegradable nerve 
guides for the repair of traumatic injury requires in vitro test-
ing. Such test models have generated 3D scaffolds consisting of 
parallel aligned polycaprolactone microfilaments upon which 
neuronal cells, Schwann cells or dorsal root ganglia can be cul-
tured. this approach results in highly aligned neuronal-glial 
co-cultures resembling “mini peripheral nerves” and, impor-
tantly, permits an organized 3D structure whereby intercellular 
contact between the Schwann cells and axons arises (Daud et 
al., 2012).
A classical approach to generate highly complex 3D in vitro 
models is the preparation of tissue slices. Acutely prepared slices 
or blocks remain viable for a few hours only, but they represent 
the models with highest resemblance to the in vivo situation. 
they have been used a lot for electrophysiological approaches 
to neurotoxicity research or for neuroprotection studies (Vol-
bracht et al., 2006). the so-called organotypic slices usually 
dedifferentiate for a while after preparation, but they can then 
be used for weeks or up to months, e.g., to study prion replica-
tion (Falsig et al., 2012) or excitotoxicity (Montero et al., 2007). 
Variations of the technology frequently use nerve explants, gan-
glion explants (especially dorsal root ganglia) or retina explants. 
All of the above technologies mainly make use of rodent tissue. 
Obtaining human tissue is not feasible for routine testing, but 
the field of stem cell research promises interesting future ap-
proaches. layered 3D cortical tissue has already been generated 
(lancaster et al., 2013), and approaches to form 3D retinal tis-
sue or adrenal tissue have also been described (Jin et al., 2011; 
Nistor et al., 2010; tsukada et al., 2013).
Another large group of 3D cultures are spheroid cultures 
formed by spontaneous aggregation of dissociated cells. Ag-
gregation may, for instance, be caused by gravity in so-called 
hanging drops (leist et al., 2012b). An alternative approach is 
the so-called re-aggregating brain cell culture. these are formed 
from dissociated rodent brain cells that undergo spontaneous 
aggregation into spheroids of a narrowly defined diameter when 
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Designing in vitro models to enable this is therefore an impor-
tant consideration. the ability to keep cultures for prolonged 
times is an important prerequisite for experiments addressing 
chronic forms of toxicity.
Improved cell-cell interactions in 3D structures, especially 
between astrocytes and neurons, may enhance neurogenesis and 
synapse formation. Functional synapses have been observed in 
three-dimensional neuronal cultures at similar or earlier time 
points compared to 2D models (O’Shaughnessy et al., 2003; 
van Vliet et al., 2007). Furthermore, neural stem/progenitor 
three-dimensional cell cultures showed an increased differentia-
tion into neurons compared with 2D cultures (Brannvall et al., 
2007). the phenotype of microglial cells is highly dependent 
on the culture conditions. Often microglial cells show an amoe-
boid morphology in 2D cultures, even in control cultures, in the 
absence of any toxicant. this is characteristic for phagocytic 
cells that have been pre-activated. However, when cultured in 
an inert 3D matrix, microglial BV-2 (Henn et al., 2009) cells 
shifted from an amoeboid form to a population dominated by 
multipolar (resting) phenotypes (Pottler et al., 2006). Further-
more, in untreated 3D aggregating brain cell cultures devoid of 
any type of inert matrix, microglial cells exhibit a ramified mor-
phology typical of quiescent cells. Only activated (directly by a 
toxicant or indirectly by injured neurons or glial cells) microglia 
exhibit amoeboid morphology (Monnet-tschudi et al., 2007). 
the presence of quiescent microglial cells in control cultures is 
due to the intense cell-cell interactions occurring in 3D between 
all brain cell types in the aggregating brain cell cultures. the 
dampening effect of brain tissue on microglia has been shown 
also by transcriptomics approaches (Higgins et al., 2010).
3.6  Issues/disadvantages of neuronal  
3D models
Some issues are specific for 3D models while others apply 
equally to 2D models. For instance, the models use mostly com-
plex culture media that do not necessarily resemble the cerebro-
spinal fluid (CSF) in brain. Also, the models usually do not have 
a barrier function that restricts access of toxicants similar to the 
blood-brain or the placental barrier.
A specific problem of 3D models may be limited compound 
diffusion to the cells. In many models and for many compounds 
this may not be an issue at all, while, e.g., for larger models and 
high molecular mass “compounds” (e.g., nanoparticles), limited 
accessibility of the cells far from the surface needs to be con-
sidered.
4  3D models of the respiratory tract
the respiratory tract has a large internal surface area (>150 m2) 
and a very thin air-blood tissue barrier (<1 µm) (Gehr et al., 
1978; Ochs and Weibel, 2008), both of which are essential for 
an optimal gas exchange between the air and blood by diffusion. 
the respiratory tract can be sub-divided into functionally and 
structurally distinct regions (Ochs and Weibel, 2008; Weibel, 
1979). Most proximally is the extrathoracic region, consisting 
of the nasal cavity, mouth, pharynx and larynx, followed by the 
performed in monolayer cell culture do not necessary identify 
in vivo toxicity (Griffith and Swartz, 2006). Thus, toxicological 
and pharmacological screenings performed in monolayer cell 
culture do not necessary identify in vivo toxicity (Griffith and 
Swartz, 2006). 
3.4  Sources of cells for 3D cultures
to provide human cellular material, which is currently seen as 
the new gold standard in toxicology of the 21st century (leist 
et al., 2008b; NRC, 2007), new technologies are emerging that 
allow differentiation of human embryonic stem cells (heSC), 
human induced pluripotent stem cells (hiPSC) or fetal neural 
progenitor cells (NPCs) into neurons and glial cells (Bal-Price 
et al., 2012; Fritsche et al., 2011; leist et al., 2008a). NSC may 
also be generated (from scratch) from human pluripotent stem 
cells that are driven towards neural differentiation. this allows 
the formation of neurospheres with highly defined characteris-
tics (Hoelting et al., 2013). Rodent neurons, glia, neural stem 
cells and tissues can be isolated from either fetal, newborn or 
adult brain. 
Although human cell systems are in the end desired for mak-
ing predictions of human health, rodent systems can also be of 
high value for risk assessment. For instance, rodent models may 
be used in parallel to a human cell-based model. By using both 
cultures, neurotoxicity observed in human cells in vitro can be 
extrapolated to the large database on neurotoxicity in rodents 
in vivo. Such species extrapolations that use comparison of in 
vitro and in vivo data are called the “parallelogram approach 
of toxicology”. For instance, species-specific differences in 
sensitivity observed between human and rat organoid cultures 
are most likely to reflect, and to predict, disparities in cellular 
toxicodynamics. these experimentally-derived toxicodynamic 
factors can then be employed for hazard and risk assessment. 
However, degrees of maturation between human and rodent sys-
tems have to be carefully assessed, as speed of maturation dif-
fers between species, not only in vivo but also in vitro (Baumann 
et al., 2014).
3.5  Benefits and advantages of neuronal  
3D models
Often, 3D models result in improved structure and cell con-
nectivity. Moreover three-dimensional cultures often show en-
hanced survival and neuronal differentiation compared to tradi-
tional monolayer cultures (Brannvall et al., 2007; Peretz et al., 
2007). the enhanced survival could be related to the improved 
cell-cell and cell-matrix contact, as it improves cell signaling 
and gap junction connections, but these factors may need fur-
ther investigation, as also in vivo survival after, e.g., injection of 
cells in the brain is still not clarified (Hansson et al., 2000; Schi-
erle et al., 1999). Cell-cell signaling can also promote prolifera-
tion and differentiation of glial and neural stem cells, which in 
turn contributes to improved culture longevity and functional 
relevance. local secretion and paracrine signaling of neuro-
trophic factors, such as nerve growth factor (NGF) and brain-
derived neurotrophic factor (BDNF), together with intercellular 
communication between neuregulin-1 and Necl4 are important 
in this regard (Maurel and Salzer, 2000; Michailov et al., 2004). 
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signaling to maintain homeostasis and to coordinate immune 
responses (Roggen et al., 2006). However, these models fail to 
provide organ-level functionalities (molecular transport across 
tissue-tissue interfaces, contributions of vascular and air flow, 
etc.) that are required for the development of meaningful physi-
ological models (Huh et al., 2011, 2012b). A potential solution 
to this problem is the development of human “organs-on-chips” 
in which microscale engineering technologies are combined 
with cultured living human cells to create microfluidic devices 
that recapitulate the physiological and mechanical microen-
vironment of whole living organs (Huh et al., 2011, 2012b). 
these organomimetic microdevices enable the study of com-
plex human physiology in an organ-specific context and, more 
importantly, they offer the potential opportunity to develop spe-
cialized in vitro human disease models that could revolutionize 
drug development. 
In vitro co-cultures to mimic the alveolar epithelial barrier 
with two cell types have been described in the literature. two 
cell co-culture models with epithelial (A549 cells) and endothe-
lial cells were established to examine events in the pathogen-
esis of bacteria (Bermudez et al., 2002; Birkness et al., 1995). 
Recently, a primary co-culture system to simulate the human 
alveolar-capillary barrier by using primary cells was developed. 
Human pulmonary microvascular endothelial cells were co-cul-
tracheobronchiolar region, consisting of the trachea, main bron-
chi, bronchi and bronchioles including the terminal bronchioles. 
the main tasks of this region are air conditioning and air conduc-
tion. Ambient air is efficiently modified and cleansed of much 
of the larger particulate material by mucociliary activity (fast 
particle clearance) before being conducted deep into the lungs. 
the tracheobronchiolar region is followed by the proximal part 
of the alveolar-interstitial region, consisting of the respiratory 
bronchioli with only a few alveoli, the task of which is air con-
duction, a small amount of gas exchange and slow clearance of 
particulate material. the distal part of the alveolar-interstitial re-
gion consists of the most peripheral airways, the alveolar ducts, 
with their “walls” completely covered with alveoli (i.e., alveolar 
entrances), and the alveolar sacs (i.e., alveolar ducts with alveoli 
closing the end of the terminal ducts), including the interstitial 
connective tissue. the main task of this region is gas exchange 
of oxygen and carbon dioxide with the blood (Gehr, 1994).
A series of structural and functional barriers protect the res-
piratory system against both harmful and innocuous particulate 
material (Nicod, 2005). the barriers comprise the surfactant 
film (Gil and Weibel, 1971; Schurch et al., 1990), the aqueous 
surface lining layer including the mucociliary escalator (Kil-
burn, 1968), macrophages (professional phagocytes) (Brain, 
1988; lehnert, 1992), the epithelial cellular layer endowed with 
tight junctions and adherens junctions between the cells (God-
frey, 1997; Schneeberger and lynch, 1984), and a network of 
dendritic cells (DCs) inside and underneath the epithelium (Holt 
and Schon-Hegrad, 1987; McWilliams, 2000). In the respira-
tory tract, dendritic cells (DCs) crucially maintain the fragile 
equilibrium between induction of tolerance against innocuous 
substances and mounting an active immune response against a 
potentially harmful pathogen. Besides the lung epithelium, the 
basement membrane (Maina and West, 2005), the connective 
tissue (Dunsmore and Rannels, 1996), and the capillary en-
dothelium (Dudek and Garcia, 2001; Schneeberger, 1977) serve 
as structural barriers.
4.1  In vitro respiratory tract models
Since the morphology and function of the respiratory tract 
changes completely from the upper to the lower airways, many 
cell culture models have been established using primary cells or 
cell lines to represent the area of interest for a certain study. 
there are numerous different in vitro models that can be used 
to evaluate the human pulmonary epithelial tissue barrier, such 
as epithelial airway or alveolar cells. they range from simple 
2D monocultures (Fuchs et al., 2002; Steimer et al., 2005) to 
highly sophisticated 3D models involving different cell types 
(Rothen-Rutishauser et al., 2008). the 3D models represent a 
more realistic physiological situation (Carterson et al., 2005). 
Studies have shown that when cells are removed from their 
host tissue and are grown as monolayers on impermeable sur-
faces, they undergo dedifferentiation and lose specialized func-
tions, which is thought to be, in part, due to the disassociation 
of cells from their native three-dimensional tissue structure in 
vivo (Freshney, 2000). Co-cultures of different cell types have 
been shown to have an influence on the outcome of the results, 
since cells continuously cross-talk in vivo through intercellular 
Fig. 6: Schematic representation of 3D in vitro models of lung
Many co-cultures mimicking the alveolar barrier are described in 
the literature (A). The most common approach is to use permeable 
membrane inserts in a two chamber system with epithelial cells 
grown on the upper side and endothelial cells on the opposite (B). 
Design of the triple cell co-culture composed of epithelial cells 
with macrophages on top and dendritic cells on the opposite of 
the insert membrane. (C) The microfabricated lung device uses 
compartmentalized polydimethylsiloxane (PDMS) microchannels 
to form an alveolar-capillary barrier on a thin, porous, flexible 
PDMS membrane coated with extracellular matrix. The device 
recreates physiological breathing movements by applying vacuum 
to the side chambers and causing mechanical stretching of the 
PDMS membrane forming the alveolar-capillary barrier (reprinted 
with permission from Huh et al., 2010).
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PDMS, the entire human inflammatory response can be visual-
ized in real-time within this microdevice (Huh et al., 2011). 
the lung-on-a-chip has been used for nanotoxicology studies 
by introducing various types of nanoparticles into the air chan-
nel. these studies revealed that physiological breathing move-
ments accentuate toxic and inflammatory responses of the lung 
to silica nanoparticles (12 nm) used to mimic airborne particu-
lates. Mechanical strain also enhanced epithelial and endothelial 
uptake of nanoparticulates and stimulated their transport into 
the underlying microvascular channel. Importantly, similar ef-
fects of physiological breathing on nanoparticle absorption are 
observed in whole mouse lung (Huh et al., 2012b). 
Most recently, the same group has microengineered a dis-
ease model of pulmonary edema in human lungs (Huh et al., 
2012a). Specifically, they established a model of pulmonary 
edema induced by a life-threatening side effect of chemothera-
py based on interleukin-2 (Il-2), known as a vascular leakage 
syndrome (VlS). they successfully reconstituted the essential 
features of this disease including fluid accumulation and fibrin 
deposition in the lung. this disease model revealed previous-
ly unknown effects of physiological mechanical force on the 
development and progression of VlS and that circulating im-
mune cells are not required for the development of this disease. 
These studies also led to identification of potential new thera-
peutics that might prevent this life-threatening toxicity of Il-2 
in the future. these data demonstrate the ability to leverage the 
unique capabilities of the human lung-on-a-chip microdevice 
to create a clinically relevant human disease model in vitro, 
and ultimately to reliably predict drug toxicity and efficacy in 
humans. Importantly, these findings suggest that a microengi-
neered in vitro human disease model can potentially replace 
preclinical animal models of pulmonary edema currently used 
by the pharmaceutical industry to evaluate the effects of drugs 
on VlS in the lung. 
4.3  Issues/disadvantages of 3D lung models
One of the main problems for 2D as well as 3D lung mod-
els is that no cell line – neither for the upper nor the lower 
airways – exists that represents the optimal function-structure 
relationship. On the other side, the isolation and handling of 
primary cells is much more time-consuming and the variability 
between the different isolations is high. therefore, the limita-
tion of each model which has been described so far needs to be 
carefully considered for the interpretation of observed effects. 
In addition, since the lung surface is exposed to air, the cell 
model(s) also need to be cultured at the air-liquid interface to 
mimic the lung more realistically. This is however difficult to 
perform over longer exposure durations due to the limited life 
time of the cells (i.e., mainly a problem for cell lines) and/or 
due to an overgrowth of cells forming multiple cells instead of 
a monolayer (Paur et al., 2011). In addition, the vast majority 
of lung models are still lacking in mimicking the specific me-
chanics of the lung surface. In particular, they typically present 
a static air-liquid interface, which is clearly unrealistic given 
the cyclical motion of the alveolar surface during breathing. 
A recent exception is provided by Huh and colleagues (Huh 
et al., 2011) whose lung on a chip model features mechani-
tivated with primary human type II alveolar epithelial cells on 
opposite sides of a permeable filter support to study the impact 
of nanocarriers (Hermanns et al., 2009 2010).
Recently, a triple cell culture in vitro model of the human 
airway wall to study the cellular interplay and the cellular re-
sponse of epithelial cells, human blood monocyte-derived mac-
rophages and dendritic cells to particles (Rothen-Rutishauser 
et al., 2008) has been developed. In this model, monolayers of 
two different epithelial cell lines representing alveolar as well 
as bronchial regions, A549 (Rothen-Rutishauser et al., 2005) 
and 16HBe14o- epithelia (Blank et al., 2007), as well as prima-
ry epithelial type I cells (lehmann et al., 2011), can be grown 
on a microporous membrane in a two chamber system. In addi-
tion, a quadruple-culture containing epithelial and endothelial 
cells, macrophages, as well as mast cells, has been established 
(Alfaro-Moreno et al., 2008). Studies using such co-culture 
cell systems have reported that they observe different reactions 
compared to monoculture analysis when the cells are exposed 
to nanomaterials (lehmann et al., 2009; Muller et al., 2010); 
however, such reactions observed from a culture containing 
two, three or four different types of cells merely cultured in 
the same dish, are not as specific as those that would occur in 
the human body. thus, the architecture of the in vitro cell co-
culture model, in regard to the specific organ they represent, 
is essential when nanomaterials’ effects are studied. Figure 6 
shows the schematic representation of 3D in vitro models of 
lung for transwell co-culture technique and the currently most 
advanced in vitro lung model.
4.2  Benefits and uses of 3D organotypic 
respiratory system models
the recently (micro)engineered “lung-on-a-chip” reproduces 
key structural, functional and mechanical properties of the liv-
ing lung by microfabricating a microfluidic system containing 
two closely apposed microchannels separated by a thin (10 
µm) porous flexible membrane made of polydimethylsiloxane 
(PDMS) (Huh et al., 2010). the intervening membrane was 
coated with extracellular matrix (eCM), and human alveolar 
epithelial cells and human pulmonary microvascular endothelial 
cells were cultured on opposite sides of the membrane. Once the 
cells were grown to confluence, air was introduced into the epi-
thelial compartment to create an air-liquid interface and more 
precisely mimic the lining of the alveolar air space. In addition, 
this microsystem reproduces breathing movements and the as-
sociated cyclic strain experienced by cells at the alveolar-capil-
lary interface by applying cyclic suction to neighboring hollow 
microchambers that deforms the central porous membrane and 
attached cell layers. 
Most importantly, this lung-on-a-chip microdevice repli-
cates the complex organ-level responses of living human lung 
to physiological inflammatory stimuli, such as bacteria or cy-
tokines introduced into the air space. the underlying endothelial 
cells rapidly become activated in response to these cues, which 
induces adhesion of primary human neutrophils flowing in the 
capillary channel, as well as their transmigration across the cap-
illary-alveolar interface and into the alveolar space where they 
then engulf the bacteria. Because of the optical clarity of the 
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has been shown, for example, by the spontaneous chromosomal 
aberrations in immortalized keratinocytes. this raises the ques-
tion of whether monolayer-based (2D) assays are suitable for 
drug development.
Although skin metabolism takes place mostly in epidermal 
keratinocytes, only 3D constructs mimic xenobiotic biotransfor-
mation in human skin properly.
In the 1980s it first became feasible to predict cytotoxicity 
(OeCD, 2013a), phototoxicity (in 3t3 cells; (OeCD, 2004a)) or 
induction of cell migration (scratch assay) using 2D assays. In 
fact, OECD guideline 432, adopted in 2004, is the first in vitro 
test replacing hazard analysis in the animal almost entirely (with 
drug development being the only exception). But monolayer 
cultures cannot be used to investigate percutaneous absorption 
or biotransformation of compounds, and processes involving 
these (e.g., systemic toxicity, skin sensitizing and genotoxicity) 
therefore require more complex approaches. In contrast, mul-
tilayer (3D) reconstructed human epidermis has proved to be 
suitable for in vitro skin absorption testing. A schematic set up 
for reconstructing human skin is shown in Figure 8. 
In addition, monolayer cultures do not mimic cell-cell inter-
actions of a multilayer tissue consisting of different cell types. 
Several types of cells contribute to skin function in order to pre-
vent damage by UV irradiation, xenobiotics or microorganisms. 
Skin morphology varies during lifetime and according to the 
body site. Disturbed barrier function and/or immunosuppres-
sion lead to severe or chronic/recurrent diseases (e.g., cancer, 
septicemia or atopic dermatitis). 
cal stretching of an interface combining alveolar epithelial and 
microvascular endothelial cells to simulate the dynamics of 
breathing. this microenvironment with the mechanical activa-
tion can maintain cells in culture for several weeks. these cells 
also exhibit more highly differentiated phenotypes when pre-
sented with physiologically relevant microenvironmental cues 
than when maintained under conventional 2D or 3D culture 
condition.
5  3D models of the skin
the skin is the largest organ of the human body and also the 
first “line of defense” against many external insults. All manner 
of chemicals, cosmetics and medicines must be tested for skin 
irritation and/or sensitization. this has been a major source of 
animal use in testing, particularly for cosmetics. even before the 
recent outlawing of animal testing in cosmetics in the european 
Union, in vitro skin testing was perhaps the furthest along of all 
alternative testing methods, regarding acceptance by regulatory 
authorities and use in toxicological testing.
5.1  In vitro skin models
Human keratinocyte and fibroblast monolayer cultures are well 
established (Fig. 7), particularly ones using murine fibroblasts 
(3t3 cells) and the spontaneously transformed human kerati-
nocyte cell line HaCaT. However, the latter does not reflect the 
primary keratinocyte in situ, which can be easily visualized, and 
Fig. 7: In monolayer culture, cellular morphology differs from 
in vivo morphology
Upper picture: Fibroblasts in monolayer culture on lamella 
observed by scanning electron microscopy (SEM): population sub-
confluence. Cells have rather starry shapes. Length of the line 10 
μm (Image: A. Minondo, L’Oréal); lower pictures: human fibroblasts 
project a dendritic network of extensions in collagen matrices but 
not on collagen-coated coverslips. Fibroblasts were incubated for 
5 h on collagen‐coated surfaces (A) or in collagen matrices (D). 
At the end of the incubations, samples were fixed and stained for 
actin. Reprinted with permission from Grinnell et al. (2003).
Fig. 8: Reconstructing human skin 
Normal fibroblasts and keratinocytes are isolated from, e.g., 
human foreskin and expanded in monolayer culture. Fibroblasts 
are embedded into a collagen matrix (step 1) and the collagen is 
allowed to contract (growth medium). Keratinocytes are seeded 
on top and medium is changed to differentiation medium (step 
2). Finally the culture is lifted to the air-medium interface (step 3). 
Total culture duration is about 14 days. For the reconstruction of 
human epidermis step 1 is omitted and keratinocytes are seeded 
on a supporting membrane.
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eCM are possible. Moreover, the communication distance in a 
3D scaffold is determined by the cell distribution and not by the 
artificial gap between well plate and porous membrane. In con-
clusion, culture of cells in 2D is far too artificial and lacks many 
parameters known to be important for an accurately reproduced 
tissue structure and physiology.
Recently, several more advanced states of tissue culturing 
have been realized. Co-culture of reconstructed human skin 
with malignant cells has been used for nonclinical assessment 
of photodynamic therapy. Candida albicans seeding allows 
building mycosis models for the analysis of host-pathogen in-
teractions at the molecular level. Moreover, gene silencing in 
normal human epidermal keratinocytes can be used to generate 
diseased skin models, such as for congenital ichthyosis by cor-
neodesmosin knock down or diseases linked to a barrier defect 
by filaggrin knock-down.
Development of 3D models for non-melanoma skin cancer, 
candidiasis and loss of barrier function was a priority in 3D 
model development due to the prevalence of these diseases. 
Mycoses have become a major health problem: the frequen-
cies of mucosal and cutaneous fungal infections are increasing 
worldwide and host immunosuppression facilitates invasive 
candidiasis, resulting in septicemia. Oral and vaginal mucosa 
models of epithelial candida infections based on commercially 
available reconstructed tissues offer a faster approach for the 
development of new drugs. the value of these models cannot 
be over-estimated, since pathological processes in the current 
in vivo guinea pig model do not reflect mucosal fungal infec-
tions and it is difficult to compare guinea pig cutaneous fungal 
infections to fungal infections in humans. Non-melanoma skin 
cancer is also a major health problem: increased incidences of 
non-melanoma skin cancer and invasive and life-threatening 
diseases due to immunosuppression as treatment, in particular 
in organ transplant receivers, are a major cause of morbidity 
and mortality. Field cancerization, in which dozens of lesions 
occur simultaneously, requires efficient field-directed therapy. 
Recently, the efficacy of one approach, photodynamic therapy, 
was assessed by reconstructed human skin integrating malig-
nant cells. Atopic dermatitis affects currently about 10-20% of 
children and 1-3% of adults. Although atopic dermatitis models 
do not reflect the multifactorial disease pattern in full, a well-
characterized model can be used for testing of glucocorticoids 
or calcineurin inhibitors and the respective formulations for 
topical use.
5.3  Disadvantages of 3D skin models
the general procedure of building, maintaining and character-
izing 3D skin models is published; these well-known techniques 
are then further adapted to disease models. But the current 3D 
constructs need much more detailed characterization, going be-
yond morphology and lipid analysis. to be used for regulatory 
purposes the construct itself has to reflect the in vivo situation 
and the methodology for proving efficacy and/or identifying 
hazards has to be validated, and then achieve regulatory accept-
ance. Successfully navigating this process will allow 3D con-
structs and disease models to be used as alternatives to animal 
or 2D approaches. 
5.2  Benefits and uses of 3D organotypic  
skin models
Multilayer skin constructs represent only epidermis or only 
epidermis plus dermis. Reconstructed human epidermis, built 
up by proliferating and differentiating human keratinocytes, 
or reconstructed human skin (full-thickness skin construct), in 
which the epidermis equivalent covers a fibroblast embedding 
collagen layer, are state-of-the-art in dermal tissue engineering. 
Constructs of high quality are commercially available (Fig. 8); 
these are close to native human skin in terms of morphology, 
lipid composition and differentiation. these approaches are in-
tended to address issues in which 2D assays fail due to the lack 
of the extensive barrier of intact skin. examples can be found 
in OeCD tG 432 (tiered test for phototoxicity, if a substance is 
suspected to penetrate skin only poorly), OeCD tG 431 (test 
for skin corrosion) or OeCD tG 439 (skin irritation) (OeCD, 
2004a, 2013a,b). 
In most 3D-models, a scaffold provides the geometrical struc-
ture for tissue growth. Additionally, scaffolds can present rel-
evant markers and proteins to foster cell adhesion and to guide 
tissue development. Furthermore, a scaffold can support the 
development of sophisticated co-culture systems. the third di-
mension allows the culture of different cell types in a tissue-
specific formation. For instance, full-thickness skin equivalents 
are comprised of a dermal and an epidermal layer (Fig. 3A). In 
each layer, specific cells are cultured. The dermal layer is usu-
ally generated by seeding fibroblasts into a collagen hydrogel 
scaffold. to mimic the basement membrane of the skin, the sur-
face of the dermal compartment can be coated with fibronectin. 
This artificial basement membrane allows for the culture of ke-
ratinocytes. to include an additional barrier, the bottom surface 
can be populated with endothelial cells. 
One approach to generate 2D co-culture models is to use 
porous membranes in order to establish different culture com-
partments based on the insert technology. A specific cell type 
is seeded in each compartment. Cellular cross talk between the 
two cell types is restricted to diffusion in the liquid phase and 
across the pores of the membrane. therefore, concentration gra-
dients have to be established that are strongly determined by the 
pore parameters such as pore diameter, porosity, pore length, 
and the diffusion coefficients of the messenger substances in 
the cell culture media. In more complex liquid systems, such as 
blood plasma, the diffusion coefficients of proteins, e.g., urea, 
creatinine, and uric acid, are approximately 30% lower com-
pared to water. therefore, mass transport is biased when com-
pared to the in vivo situation, which has a significant impact on 
patterning that is based on the spatial and temporal distribution 
of messenger proteins. Patterning guides tissue or cell develop-
ment, and thus, the 2D model may have different structural or 
functional properties in comparison to native tissue due to the 
parameters of the experimental setting such as pore diameter or 
membrane thickness. 
In contrast, the 3D environment in a scaffold fosters a higher 
complexity of cellular cross talk. Messenger proteins diffuse in 
an extracellular matrix (eCM) and, hence, the diffusion is af-
fected by the eCM components. Additionally, further mecha-
nisms such as protein binding to specific binding sites of the 
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and the dog (Bailey et al., 2013). today, reconstructed human 
epidermis (RHe) is commercially available in high quality (e.g., 
epiDerm™, Skinethic™, epiSkin™) for hazard analysis (Fig. 
9). RHe from other origin (in-house constructs, Open-Source 
Reconstructed epidermismodell, OS-Rep) also can be used if 
quality is proven. 
Keratinocytes cannot reproduce all the physiological proc-
esses present in human skin. this underlines the need for more 
complex constructs to address complex toxicological endpoints. 
Micro-environmental factors, such as the dynamic crosstalk be-
tween epithelium and connective tissue, are known to regulate 
epidermal morphogenesis and homeostasis. thus, reconstruct-
ed human full-thickness skin (RHS) presenting an additional 
dermal layer (commercial products: epiDerm Ft™, Phenion-
Ft™) may be helpful. Because of differences in enzyme ex-
pression in keratinocytes and fibroblasts RHS may be superior 
to RHe when investigating dermal biotransformation of xenobi-
otics and related endpoints (sensitization, genotoxicity). Further 
advancements of RHS, such as long-term stable constructs and 
models with co-cultured dendritic cells, are highly desirable for 
several applications.
5.4  Key issues of normal reconstructed  
human epidermis (RHE)
Reconstructed from human non-transformed epidermal kerati-
nocytes, RHE closely mimics the morphological (well-stratified 
epithelium with basal, spinous, granulous and corneal layers), 
biochemical and physiological properties of the human epider-
mis. Quality assurance according to OeCD tG 431 (OeCD, 
2013a) includes the declaration of cell types, cell handling, type 
of the construct, histology, immunohistology, lipid analysis, 
permeability for standard substances as well as resistance to 
irritants. the barrier function is highly relevant for the use of 
RHe in hazard analysis.
Constructs are built from keratinocytes isolated from juve-
nile foreskin or adult abdominal/breast skin and expanded in 
culture media. the cells are seeded into transwells, and after a 
short submersed cultivation an airlift is performed in order to 
induce keratinocyte differentiation, which is a continuous proc-
ess. After about two weeks keratinocytes will be fully differ-
entiated and all the epidermal layers of normal human skin are 
presented. transcriptome analysis proved human skin and RHe 
to be similar to each other, expressing epidermal differentiation 
markers – e.g., filaggrin, loricrin, involucrin, receptors and tran-
scription factors. In contrast, the expression of many cell cycle 
and DNA replication genes and the lack of differentiation mark-
ers prove that keratinocytes in monolayers fail to differentiate 
(Gazel et al., 2003).
lipid analysis demonstrated great similarities of stratum cor-
neum lipids between normal human skin and RHe. Differences 
in specific lipids (e.g., less essential long-chain free fatty acids 
in RHe) and in particular the lipid order (native human stratum 
corneum presents two lamellar phases with repeat distances of 
13.4 and 6.4 nm, RHe presents long periodicity only), however, 
can explain the poorer barrier function. this might be even worse 
with RHe grown from the HaCat cell line which showed an im-
paired capacity for lipid synthesis (Ponec et al., 2001). Currently, 
though quite advanced, current 3D constructs still do not yet 
contain all essential cell types – in particular dendritic cells are 
most difficult to (co-)culture. However, they are needed for re-
alistic models of a number of important diseases, such as atopic 
dermatitis and psoriasis. Some initial approaches of embedding 
macrophages into dermal equivalents are described in the lit-
erature, but they still need improvement regarding epidermal 
structure. An epidermis close to the in vivo situation is impera-
tive, particularly to recapitulate complex pharmacokinetics 
and pharmacodynamics. Another important step is to integrate 
blood vessels or, at least, an endothelial layer, below the dermal 
equivalent. this type of integrated skin would be a major part of 
the “body-on-a-chip”, mentioned previously.
Finally, from a supply-perspective, the broad spectrum of 
potential 3D construct applications as well as a major increase 
in ReACH-based testing will likely lead to primary cell short-
ages. To ensure sufficient supply of primary cells, inducible 
stem cells offer a viable option. Besides the general approach 
of cell-differentiation, there is a more specific one with respect 
to keratinocytes: Progenitor cells are found in hair bulbs, which 
are removed by hair plugs and can be expanded for reconstruc-
tion of human epidermis.
Research in the field of alternative testing has been reinforced 
in order to avoid the testing of cosmetics and ingredients of 
cosmetic formulations in animals (leist et al., 2008b). In vivo, 
the toxicity of a test substance is the result of complex events 
involving multifactorial and dynamic physiological processes. 
these mechanisms are dependent on the interaction between the 
substance and the cell as well as skin penetration, metabolism 
or inactivation. Although an in vitro model cannot reproduce all 
the events observed in vivo, in vitro assays based on 3D mod-
els constructed using human cells are very powerful tools. they 
are a simplified representation of reality that allows studying 
a compound under standardized conditions with controlled pa-
rameters. this given, 3D models may even allow to overcome 
the high failure rates in clinical testing because of the poor 
transferability of animal data to man (Hartung, 2007; Hartung 
et al., 2013), both with respect to rodents (Seok et al., 2013) 
Fig. 9: Histology of a reconstructed epidermis, EpiSkinTM 
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et al., 2011) or CD34+ cells after keratinocyte seeding. epider-
mal langerhans cells and dermal dendritic cells can be formed 
depending on the culture condition (Dezutter-Dambuyant et al., 
2006; Auxenfans et al., 2009).
5.6  Benefits of 3D skin constructs and  
special requirements 
In monolayers, the cells are immersed in an aqueous culture me-
dium which limits the testing to water soluble substances. RHe 
overcomes this limitation and various substances and various 
vehicles (liquid, powder, gel ...) can be applied directly to the 
skin surface. 3D constructs enable the investigation of dermal 
penetration and various biological effects in the skin can be de-
rived by quantitation of several biological endpoints, e.g., by 
biomarkers or two-photon microscopy
Primary cells are preferred for 3D models due to their wild-
type nature, which translates to in vitro cultures with cells pre-
serving better the structural and biochemical complexity found 
in vivo. Yet, primary cells are most sensitive to their surround-
ings, handling and use require sophisticated techniques and ad-
vanced tissue culture training in order to obtain the high level 
of organization of 3D constructs. Cell migration and differentia-
tion are very sensitive to any modification of the culture envi-
ronment. this multiplies sources of variability in the resulting 
3D models and RHe/RHS require distinct quality control dur-
ing their life cycle. test protocols must always include assay 
acceptance criteria (negative and positive controls, comparison 
to historical data, replicates, etc.).
a construct with a barrier as good as human skin is not available 
(Thakoersing et al., 2012). The investigation of specific effects of 
defined stratum corneum lipids on the barrier function becomes 
possible by, e.g., spraying lipid mixtures dissolved in organic sol-
vents onto an appropriate support material (Groen et al., 2011).
5.5  Key issues of normal reconstructed  
human skin (RHS) 
Full-thickness human skin (RHS) can be reconstructed from 
human keratinocytes seeded on collagen-embedded fibroblasts 
(Fig. 10). Quality assurance is as described for RHe. Morphol-
ogy of the constructs – including fibroblast morphology and the 
organization of cell-derived matrix components (Cukierman et 
al., 2001) – and lipid formation is close to normal human skin. 
the order of stratum corneum lipids is not perfect but improves 
over time whereas the skin surface pH 5.5 is well in accord-
ance with human skin already in the early stage of development 
(Vávrová et al., in press). this holds true also with a construct 
generated from the HaCat cell line replacing primary keratino-
cytes. Acidic pH at the skin surface increased up to 7.0 in deeper 
layers. In the intercellular matrix pH is ≤ 6.6 (Hanson et al., 
2002; Niesner et al., 2005). 
3D constructs, which are stable for up to 6 months, appear 
to make it possible to avoid collagen as a component of the 
dermal equivalent (Stark et al., 2006). Other major aims are 
the construction of vascularized and immune-competent skin, 
which may become possible by integration of, e.g., a vascular 
endothelial cell line and dermal-type macrophages (Bechetoille 
Fig. 10: Matrix effects on 3D RHS 
Both 3D organization and cell-derived matrix components are required for formation of 3D matrix adhesions (triple label localization of 
α5 integrin (green, A), paxillin (red, B), and fibronectin blue, (B)) in RHS. The yellow color (A) represents the merged labels of α5 in green 
and paxillin in red. Triple merged images for the indicated matrices are shown in (C) to (F). Note that complete triple co-localization (white) 
is observed only with in vivo-like, cell-derived 3D matrix (C) or mouse tissue-derived 3D matrix (F) in 3D matrix adhesions (arrows). 
Reprinted with permission from Cukierman et al. (2001).
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sives into 3 subcategories (1A – severe, 1B moderately severe, 
and 1C minor danger) and GHS 1A classification of a chemical 
has huge impact on transport and storage conditions. OeCD tG 
431 now allows a classification according to the categories 1A 
and 1B/1C. Adoption of a revision of OeCD tG 439 (OeCD, 
2010b) is expected by 2014, once more in order to allow classi-
fying substances in GHS categories. Category 3 (mild irritants) 
is optional in europe but required in some countries and by 
some authorities (Kolle et al., 2012). 
Corrosivity and irritancy testing is based on the Mtt reduc-
tion test. A limitation of this read-out is the non-specific interac-
tion of Mtt with some test substances (colored substances, test 
substances that directly reduce Mtt). then, additional steps 
have to be taken and the test substance may even be incompat-
ible with the test system. In order to extend the applicability 
domain, dead tissue may be used for control. Alternatively, the 
quantification of ATP levels can solve the case of direct MTT 
reducers. For colored substances, use of HPlC as complement 
to photometry is currently assessed to address this limitation. 
Another widely accepted test for hazard analysis is photo-
toxicity testing with RHe as an adjunct test to the 3t3 Neu-
tral Red Uptake Phototoxicity test (3t3 NRU Pt; OeCD tG 
432 (OeCD, 2004c)). Despite the fact that the 3t3 NRU Pt is 
over-sensitive (lynch and Wilcox, 2011), it is still considered 
to be the first test in a tiered testing phototoxicity strategy as 
the assay identifies the phototoxic hazard with 100% sensitiv-
ity (Ceridono et al., 2012). Other than monolayers, the barrier 
function of RHe limits access of substances to viable cells. Yet, 
until today a formal validation of phototoxicity tests using 3D 
models is lacking.
the complex cascade of events underlying skin sensitiza-
tion asks for an integrated testing strategy for the replacement 
of animal testing (local lymph Node Assay, llNA (OeCD, 
2010a)). The compound̓s penetration into viable skin, the po-
tential biotransformation, the covalent binding to proteins and 
the activation of keratinocytes and dendritic cells and subse-
quent processing resulting in the expression of surface markers 
of activated dendritic cells have to be tested stepwise (Mehling 
et al., 2012). Among the most advanced in the validation proc-
ess at eCVAM are the direct peptide reactivity assay (DPRA), 
the KeratinoSens™ assay and the human cell line activation test 
(h-ClAt). these assays cover three key steps: protein reactiv-
ity, keratinocyte activation and dendritic cell activation. Most 
recently, two reports have demonstrated that the combination of 
these methods yields a high accuracy to predict skin sensitizers 
(Bauch et al., 2012; Natsch et al., 2013). However, these ap-
proaches, similarly to other traditional submerged cell culture 
systems, have the potential limitation that testing of substances 
presenting little or no water solubility could be a major chal-
lenge. the same is true for compounds that are instable in wa-
ter. In order to overcome these potential problems, some reports 
have suggested the use of RHe (Saito et al., 2013; teunis et 
al., 2013). Using 16 reference chemicals, the expression profile 
of five genes was in complete agreement with the results from 
llNA (Saito et al., 2013). In the future, an approach based on 
RHS co-cultured with dendritic cells may allow development of 
an alternative strategy to address this endpoint. 
5.7  RHE and RHS for studies of (per-)cutaneous 
absorption and biotransformation
(Per-)cutaneous absorption in human skin ex vivo closely ap-
proximates data obtained in humans given the protocols are 
appropriately matched (lehman et al., 2011), and as with hu-
man skin, intercorneocyte penetration is the predominant up-
take pathway of low molecular weight xenobiotics in RHe. the 
still imperfect structural organization of stratum corneum lipids 
explains the over-predictive power for (per-)cutaneous absorp-
tion of RHe. Nevertheless, using a strictly controlled protocol 
conforming to OeCD tG 428 (OeCD, 2004b) a validation 
study indicated the suitability of epiDerm™, epiSkin™, and 
Skinethic™ for in vitro absorption studies. these constructs 
were appropriate alternatives to human skin ex vivo when test-
ing nine compounds widely varying in molecular mass and par-
tition coefficient. The permeation of RHE was strongly related 
to the permeation of human epidermis sheet and the absolute 
cut-off level of penetration (800 g Mol-1) of skin and RHe was 
in accordance, too. Both infinite and finite dose experiments 
were feasible (Schäfer-Korting et al., 2008a). the protocol was 
transferable to RHS and discriminated vehicle effects (Schäfer-
Korting et al., 2008b; Ackermann et al., 2010). thus RHe/RHS 
may find a major place in (per-)cutaneous absorption testing.
In addition to the barrier function, metabolic competence of 
RHe and RHS is of relevance. Cutaneous biotransformation 
(Hewitt et al., 2013) can inactivate toxic agents, yet biotrans-
formation may also be the cause of sensitization (Hagvall et al., 
2008; Ott et al., 2009; Samuelsson et al., 2011) and genotoxicity 
(Hu et al., 2009; Brinkmann et al., 2012). this is often linked to 
the activation of a compound by biotransformation in keratino-
cytes and dendritic cells. Comprehensive investigations on the 
expression and functionality of enzymes involved in cutaneous 
biotransformation of xenobiotics in human skin ex vivo, RHe 
and RHS (Oesch et al., 2007; Harris et al., 2002; luu-the et 
al., 2009; Götz et al., 2012; Jäckh et al., 2012; Mitriaikina and 
Müller-Goymann, 2009; Bätz et al., 2013) are ongoing and the 
knowledge is currently improving. Biotransformation-compe-
tent RHe or RHS may be used for the study of penetration and 
biotransformation in a single step and RHe/RHS may be suit-
able to study genotoxicity (Aardema et al., 2010) and sensitiza-
tion (Mehling et al., 2012) of compounds in the skin. Moreover, 
the skin is also important for synthesis and metabolism of ster-
oids, and epiSkin™ expresses the enzymes for steroid metabo-
lism (van eijl et al., 2012; luu-the et al., 2007).
5.8  Choice of endpoints for hazard analysis based 
on reconstructed human skin models
the use of RHe for the study of corrosivity and irritancy is well 
established. OeCD has accepted the respective tG 431 (OeCD, 
2013a) and 439 (OeCD, 2010b). OeCD tG 431 was updated in 
2013 to include a set of performance standards for the assess-
ment of similar and modified RHE-based test methods (OECD, 
2013a). Importantly, the update also comprises the possibility 
for sub-categorization among corrosive chemicals, classify-
ing substances in the Globally Harmonised System of Hazard 
Classification and Labeling (GHS). In fact, Transportation of 
Dangerous Goods Regulations request a classification of corro-
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not improve with an extended culture period. Whereas filaggrin 
deficiency thus results in major disorder of the lipid arrange-
ment, skin surface pH is normal due to compensatory enhanced 
phospholipase activity and activation of a proton transporter 
(Vávrová et al., in press). the disturbed barrier induced by 
filaggrin silencing enhances permeability of the construct for 
the lipophilic marker substance testosterone and the resilience 
against the irritant sodium dodecylsulfate declines (Küchler et 
al., 2011). this is in accordance with the enhanced transepider-
mal water loss in atopic patients presenting filaggrin abnormali-
ties (Winge et al., 2011). Moreover, the model of peeling skin 
disease is also based on gene silencing, i.e., of transglutaminase 
(Oji et al., 2010).
In vitro skin tumor models include non-melanoma skin cancer 
(NMSC) and melanoma. For reconstruction, normal keratinoc-
ytes and a transformed cell line are seeded on a dermal equiva-
lent. the protocol (time of addition of tumor cell line, ratio of 
normal and transformed cells) determines the tissue architec-
ture. the models can be used for investigation of the impact of 
the interaction between tumor cells and their microenvironment 
on cancer progression (Carlson et al., 2008). Il-4 stimulation 
induced degradation of the basal membrane and enhanced colla-
genolysis favored tumor cell invasion (linde et al., 2012). Non-
clinical studies of anticancer drugs is also possible (Ali-von 
laue et al., in press; Hoeller Obrigkeit et al., 2009). Other co-
culture based disease models include candidiasis of epidermal, 
oral and vaginal epithelia which unraveled tlR-4 mediated de-
fense mechanisms induced by leukocyte co-cultures (Weindl et 
al., 2007; Schaller et al., 2006) and allowed demonstration of 
the efficacy of antifungal treatment (Schaller et al., 2000).
3D wound models can be generated from normal RHS, induc-
ing defined wounding, e.g., by incision of a scalpel (Carlson et 
al., 2008) or CO2 laser irradiation (Küchler et al., 2010). the 
constructs allow the histological study of key response param-
eters of wounded epithelium, such as cell proliferation, migra-
tion differentiation and growth factor responses.
5.10  Shortcomings of 3D skin models  
and future challenges
Several studies have shown that RHe is able to reproduce the 
differentiation process and exhibit all the different layers of a 
normal epidermis. the expression of differentiation markers 
(filaggrin, transglutaminase, etc.) in the lower epidermis reflects 
a hyperproliferative state of the constructs close to that seen in 
healing processes (Smiley et al., 2005) and may be overcome 
by avoiding the embedding of fibroblasts into a collagen matrix 
(Stark et al., 2006). Because of much lower barrier properties of 
current RHe/RHS, skin permeation is overestimated when com-
pared to the flux across human skin. This weakness of the barrier 
function impacts other toxicological endpoints by increasing the 
access of topically applied xenobiotics to viable skin. Although 
the predictive model of the validated protocol for skin absorp-
tion (Schäfer-Korting et al., 2008a) may corrects this, it would 
be useful to have a more physiological construct. Another limit 
of RHe and RHS is that they do not desquamate. Increasing 
the culture period causes a thickening of the stratum corneum 
and a modification of its penetrability. The lack of desquamation 
As with sensitization, a complex cascade of events also un-
derlies genotoxicity. the assessment of the genotoxic poten-
tial of compounds is primarily based on a battery of bacterial 
and mammalian in vitro cell assays allowing the detection of 
mutagenicity at the gene level, structural chromosome damage 
(clastogenicity) or numerical chromosome aberration (aneu-
genicity). However, the specificity of the mammalian cell tests 
is limited and irrelevant positive results are reported. there is 
strong evidence that the low predictivity is caused by the use 
of cell lines of less relevance with regard to metabolic capacity, 
p53 expression and/or DNA repair. Based on an appropriate cy-
totoxicity measurement the highest applied dose can be adjusted 
and thereby the experimental outcome of a study is improved 
(Fowler et al., 2012a,b). For substances in contact with the skin 
surface, cutaneous uptake and biotransformation are once more 
of pivotal relevance and RHe/RHS seems to be a suitable test 
matrix as species- and organ-specific metabolism, normal cell 
cycle control and DNA repair capacity can be assumed. 
two in vitro genotoxicity approaches using 3D skin models 
have been proposed. the human reconstructed skin micronu-
cleus (RSMN) assay combines the epiDerm® skin model with 
the established endpoint of micronuclei analysis (Curren et 
al., 2006) and allows identification of direct-acting mutagens 
as well as pro-mutagens (Aardema et al., 2013). the method 
has been transferred to other laboratories (Aardema et al., 2010) 
and a global validation study is underway. the 3D Skin Comet 
assay detects complementary DNA damage, including damage 
that arises from gene mutations. the initial approach in RHe 
used epiDerm® (Reus et al., 2013), moreover, epiDerm Ft and 
Phenion® FT were studied. Based on results generated by five 
independent laboratories (Pfuhler et al., 2010), the Phenion® 
Ft and epiDerm™ Ft were selected among the three tissues 
to enter the following validation phase, in which a total of 30 
chemicals will be investigated. Once validated, the RSMN and 
the 3D Skin Comet assay may be used as follow-ups for posi-
tive results from the current in vitro genotoxicity test battery in 
a weight-of-evidence approach.
5.9  Recombinant human skin models (RHS)  
for drug development
Other than with hazard analysis, the use of RHS for the evalu-
ation of beneficial and adverse drug effects is in its infancy. 
Glucocorticoid induced anti-inflammatory effects (decline of 
interleukin-6 and interleukin-8 secretion, histological analysis) 
were seen following the induction of inflammation by UVB ir-
radiation or TNFα exposure. Unwanted effects were observable 
by a decline in collagen amounts (Weindl et al., 2011; Zöller 
et al., 2008), which reflects the most relevant adverse effect of 
long-term topical glucocorticoid therapy, i.e., skin atrophy. 
Various disease models have been developed based on the 
techniques for the generation of normal RHS. these include 
barrier-deficient human skin, which becomes possible by 
knock-down of the filaggrin gene (Küchler et al., 2011; Mildner 
et al., 2010), which is often defective in patients suffering from 
atopic dermatitis, ichthyosis vulgaris and – possibly also – pso-
riasis (Brown et al., 2012). Other than with normal RHS, the 
order of stratum corneum lipids in the knock-down models does 
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ing (skin) diseases of the donors must be excluded, as they affect 
tissue features. For lab safety, samples containing HIV, hepatitis 
B and C, and cytomegalovirus must be excluded. Cell pooling 
of at least three donors is a way to reduce donor related variabil-
ity in routine testing, but single donor constructs are needed for 
more specific purposes. Co-culture with malignant cells raises 
the question whether to use cell lines or patient biopsies – at the 
moment there is a tendency to use well-defined cell lines. When 
integrating immune cells, the effect of activation caused by pri-
mary cells is not yet elucidated. However, the more cell types 
are integrated into a construct the more complex the timing, 
medium composition and histology, and further characterization 
may be another important step forward. the system consists of 
microchannels that reproduce a circulation system between sev-
eral organ constructs. Microfluidics provide a very fine control 
of nutrition, waste disposal and establishment of concentration 
gradients of cytokines or other biochemical substances which 
may be even closer to the situation in vivo compared to 3D con-
structs cultivated in transwells.
6  Other 3D models, such as intestine and  
tumor tissues 
Models (3D organoids) for several further organs and tissues 
have been developed. these include, for instance, lymphoid tis-
sue to address immunological niches, or they involve the cou-
pling of several organoids in multi-organoid systems. Only two 
examples are briefly described below to give a perspective on 
this wide field (Atac et al., 2013; Materne et al., 2013; Schimek 
et al., 2013; Wagner et al., 2013).
6.1  3D models of the intestine
Besides the lung-on-a-chip mentioned above, the same approach 
has been used to develop a human gut-on-a-chip that features 
peristalsis and trickling flow. This system uses a variation of the 
lung chip platform technology to develop a gut chip that is lined 
by human intestinal epithelial cells and cultured under flow con-
ditions to produce physiological shear stress (~0.02 dyne/cm2) 
while simultaneously exerting cyclic mechanical strain (10% 
elongation, 0.15 Hz). Human CaCO2 cells cultured under these 
conditions differentiate by changing their entire transcriptome 
(measured using gene microarrays) and form 3D villus struc-
tures that match the height of the microfluidic interstitial chan-
nel (Kim et al., 2012). the physiologically-relevant conditions 
recreated in the gut-on-a-chip allow the culture of living gut 
bacteria (Lactobacillus) directly on top of the living human gut 
epithelium and hence open the possibility to investigate the in-
fluence of the gut microbiome on drug and nutrient absorption 
and metabolism.
6.2  In vitro multicellular tumor spheroids (MCTS)
MCtS have been used intensively in the academic world for 
several decades. The first publications demonstrating bio-
logical differences of tumor cells in 2D and 3D go back to 
the early 70s: Folkman and Hochberg described differences 
in proliferation of tumor cells in monolayer versus spheroids 
excludes the use of the constructs for the assessment of toxicity 
induced by repetitive application of test agents.
Nevertheless, thanks to their ability to mimic skin penetra-
tion and biotransformation of chemicals RHe/RHS is essential 
to the future of toxicology. However, the road is still long to 
achieve the ultimate goal of complete replacement of animals in 
toxicology. Different ways can be explored to improve the ca-
pacity of these models to predict some toxicological endpoints 
and to facilitate their regulatory recognition.
5.11  Improvement of regulatory implementation
Integrated testing strategy (ITS) 
the one-for-one replacement vision of alternative methods (one 
in vitro test method to replace one animal study) is only possible 
for a limited number of toxicity endpoints. the way forward 
is in integrated testing strategies, in particular when addressing 
complex toxicological endpoints. ItS are stepwise processes 
which offer a framework for analyzing in a weight of evidence 
approach all the existent data and the new data generated in the 
context of the ItS. this given, ItS will allow to evaluate the 
risk of a chemical for human health. 
the ReACH system encourages registrants of substances 
to develop and implement ItS that make use of information 
from pre-existing classical in vivo toxicological experimenta-
tion, information from structurally-related substances, and data 
from in vitro methodologies and non-testing methods (including 
computational techniques), thereby minimizing the need for the 
generation of new toxicological data in vivo. Results from an in 
vitro test method may fully or partly replace an in vivo test in an 
ItS if the assay has been validated according to internationally 
agreed principles. 
Replacement of cell viability by other biological endpoints 
This point can benefit from the adverse outcome pathway (AOP) 
strategy as described in Toxicity Testing in the 21st Century: a 
Vision and a Strategy (Krewski et al., 2010). AOPs are cellular 
response pathways that, when sufficiently perturbed, are expect-
ed to result in adverse health effects. this approach is based on 
the rapidly evolving understanding of how genes, proteins and 
small molecules interact to form molecular pathways that main-
tain cell function. the goal is to determine how some chemicals 
perturb these pathways causing a cascade of subsequent key 
events leading to a toxic response. Mapping AOPs will permit 
to identify some key biomarkers specific of their activation. 
Considering the advantages discussed above, RHe/RHS should 
be powerful tools to study these pathways of toxicology and to 
assess toxic effects on a molecular level. this given, RHe/RHS 
must be comprehensively characterized (proteomics, transcrip-
tomics, metabolomics ...) to improve their predictability.
Combining skin models with other organoids
Combining the advantages of RHe/RHS with the high poten-
tial of microfluidic technologies (organs-on-a-chip; Marx et al., 
2012) offers the chance to build up donor pools with defined 
genetics.
For 3D constructs, keratinocytes and fibroblasts are most of-
ten isolated from foreskin. to build healthy constructs, interfer-
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size and metabolic activity of the cancer cells, hypoxia starts to 
develop at a diameter of 400 µm. Rodríguez-enríquez and cow-
orkers (2008) evaluated the differences in glycolysis in monol-
ayer versus spheroid cultures and measured a two- to four-fold 
increased glycolytic flux in the 3D culture providing 80% of 
total AtP consumption. throughout the spheroid, different met-
abolic regions can be distinguished, e.g., lactate concentration 
increases towards the core of the spheroid, which leads to acidi-
fication of the extracellular environment, adding an additional 
pH gradient within the spheroid.
Cell population
the spheroid format leads to heterogeneous cell populations 
within the tissue due to glucose and oxygen gradients, which 
are critical in the development of non-proliferating and non-
clonogenic cell subpopulations (Freyer and Sutherland, 1986). 
In the outer layers, the cells are proliferating; in the underly-
ing regions, the cells are non-proliferative; and in the core of 
the tissue, cells become necrotic (layering strongly depends on 
spheroid size). Moreover, tumors do not only consist of one cell 
type: tumor spheroids allow the implementation of stromal 
components such as fibroblasts and/or endothelial cells (Kelm 
et al., 2006).
The 3D format can alter drug sensitivity significantly, as 
shown for vinblastine: Multicellular drug resistance is attrib-
uted to the contacts between cells or between cells and the 
extracellular matrix. the mechanisms underlying the multicel-
lular drug resistance are still being evaluated. However, it is 
thought that hypoxia, non-proliferative cell populations, cell-
cell contacts and extracellular matrix environment impact drug 
sensitivity. the spheroid is the ideal model to study this kind 
of resistance since it so closely recapitulates patient tumor re-
sistance (Desoize et al., 1998). Importantly, however, the 3D 
format can also lead to increased drug sensitivity, for example 
for compounds which are only active in a low oxygen/hypoxic 
environment or whose targets are not expressed in 2D. In the 
early 1970s, Durand and co-workers described spheroids com-
posed of Chinese hamster V79-171b cells, containing about 
10-25 cells, which were more resistant to killing by ionizing 
radiation than their 2D counterparts. Subsequent studies re-
vealed that spheroids showed fewer radiation-induced muta-
tions than monolayers exposed to the same dose, implicating 
differences in cellular capacity to sustain and repair damage 
(Olive and Durand, 1994). 
Data analysis
Finally, the spheroid approach allows for histological analysis, 
which is not possible with monolayer cultures. this enables di-
rect morphological comparison of the in vitro model with pre-
clinical and clinical pathological assessment.
6.3  Benefits and uses of MCTS
Recently, Fayad and co-workers (2011) demonstrated the use of 
a tumor spheroid model to prioritize the hits of a screening cam-
paign to identify apoptosis-inducing compounds. they started 
with a standard 10,000 compound screen, which resulted in 
(Folkman and Hochberg, 1973). later, highly increased drug 
resistance was observed if cells were cultured as MCtS rather 
than as monolayers (Sutherland et al., 1979). even though the 
biological similarities of tumor spheroids and native tumors 
have been described over many years, this model has not yet 
found its way into routine drug discovery processes. However, 
recently the spheroid model is attracting increased attention 
as novel cell culture technologies allow its implementation in 
automated workflows, thus enabling its use in drug candidate 
screening.
Proliferating cells, such as those from tumors, show higher ex-
pression and activity of multidrug resistance transporters (e.g., 
MRP2). this was recently reported in HepG2 spheroids which 
showed highest eC50 values for tamoxifen when compared with 
collagen sandwich and monolayer cultures of HepG2 cells. the 
monolayer cultures showed no MRP2 activity (Mueller et al., 
2011a). the study also showed that the spheroids of the prolif-
erating HepG2 cells were increasing in size but the diameters 
decreased after reaching a critical size.
Growth profiling
In 1977 Yuhas and coworkers had already compared the 
growth profile of three mouse cell lines in monolayer versus 
spheroid cultures. MCtS grew at a rate that was proportional 
to the in vivo growth rate, while the growth rate of monolay-
ers did not correlate. Yuhas concluded that the spheroid allows 
for greater expression of inherent growth characteristics and 
depends less on the particulars of the media used. Furthermore 
the growth profile of the spheroids depends not only on cel-
lular doubling times but also on the size of the microtissue 
(Yuhas et al., 1977).
Diffusion resistance
The efficacy and toxicity of a molecule depends strongly on its 
tissue penetration capabilities (Minchinton and tannock, 2006). 
In contrast to cells in a monolayer format, cells in a 3-dimen-
sional spheroid format develop cell-cell contacts and secrete 
high amounts of extracellular matrix (Kelm et al., 2012). Con-
sequently, this leads to increased diffusion barriers that block 
the penetration of drug molecules and biological agents. Simi-
lar diffusion barriers have to be overcome in vivo, whereas in 
monolayer cultures all cells are exposed in the same way to the 
test substance. Therefore, a concentration profile in a spheroid 
model more closely reflects the in vivo situation than a homog-
enously exposed cell population. this is of particular concern 
to companies developing large molecules such as antibodies, 
as targeted antibodies could become stuck within the first cell 
layers depending on their physical-chemical properties and the 
amount of target expressed on the cells.
Cancer cell metabolism
the aforementioned diffusion resistance in tumor spheroids 
also results in oxygen and metabolite gradients. In cancer, it is 
assumed that glycolysis is the main pathway to generate energy, 
especially in tumors with hypoxic regions. this physiological 
phenomenon is reflected in tumor spheroids. Depending on the 
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HlA subgroups or people who express particular molecular 
transporters or metabolic enzymes) so that drugs can be de-
veloped for specific human subpopulations and, eventually, so 
that virtual human clinical trials may be carried out using these 
microengineered models. In this manner, on-chip human organ 
models have the potential to accelerate the translation of basic 
discoveries into effective new treatment strategies (Huh et al., 
2011, 2012b).
7.2  Issues/disadvantages of 3D organ-on-a-chip 
models
3D organ-on-a-chip models represent a great improvement 
over planar 2D models in recapitulating organ-level function-
ality. Reconstituting the appropriate tissue microarchitecture, 
complex biochemical milieu and dynamic mechanical micro-
environment (e.g., cyclic mechanical strain, fluid shear) have 
been key in these improvements (Huh et al., 2011, 2012b). As 
discussed previously, a key challenge will be identifying the op-
timal source of human cells that best mimic in vivo responses. 
Recent organ-on-a-chip studies suggest that established human 
cell lines can be used to model complex lung functions (e.g., 
inflammatory response) in vitro and that these cells exhibit more 
highly differentiated phenotypes when presented with physi-
ologically relevant microenvironmental cues than when main-
tained under conventional 2D or 3D culture conditions (li et al., 
2012). Inducible pluripotent stem (iPS) cells or embryonic stem 
(eS) cells may provide a solution, however, additional develop-
ment is required in order to drive these cells from a neonate-like 
state to the more mature adult phenotype required for use in 
organ-on-a-chip microsystems. 
While organ-on-a-chip systems can be designed and devel-
oped by leveraging engineering principles to provide the re-
quired function/physiology, several issues will need to be ad-
dressed to allow for broader utility. these include overcoming 
technical issues and complexity from a manufacturing perspec-
tive, implementation and ease of use in the laboratory, automa-
tion, as well as developing intuitive and easy user interfaces. 
technical challenges include integrating these organ chips with 
sensors that can detect and measure optical, chemical, electrical 
and mechanical signals from the cells, development of auto-
mated flow and pressure control within the microfluidic devices 
and multiplexing these microsystems for higher-throughput 
analysis and screening. Also, in order to move towards large 
scale commercial manufacturing, novel materials will need to 
be developed that are more amenable to mass production. Poly-
dimethylsiloxane (PDMS) is most commonly used in micro-
fluidic systems because of its optical transparency, flexibility, 
biocompatibility and fabrication by casting. However, small 
hydrophobic molecules can partition into the bulk of PDMS, 
which limits its utility for drug development applications. Re-
cently, alternative materials that are resistant to absorption of 
small hydrophobic molecules but are similar to PDMS in terms 
of optical transparency, flexibility and castability, have been 
identified (Domansky et al., 2013). 
Future in silico modeling paradigms will need to be devel-
oped to utilize endpoints generated within these systems and 
about 400 hits. these hits were further assessed on a 3D model 
of the same cell type. Using the same concentration as in the 
monolayer screen, the number of hits was reduced by a factor 
of 10. Further decreasing the concentration in a third screening 
round, the number of hits was reduced to 11. Interestingly, if 
only the 100 most potent 2D hits had been investigated, 10 of 
the 11 final 3D hits would have been lost.
6.4  Issues/disadvantages of MCTS
Current approaches to produce spheroids are highly manual, 
low-throughput processes, which are not industry-compatible. 
However, new technologies are emerging that address robust 
automation-compatible production processes, allowing repro-
ducible production of tumor spheroids. the spheroid approach 
to coax cells into the third dimension does not require the ad-
dition of foreign material, but even so biochemical assays may 
require adaptation. tissue lysis is more complex due to high 
quantities of extracellular matrix and high content analysis be-
comes more challenging as the z-dimension is greatly increased 
and the signal from fluorescent dyes can only be detected to a 
certain depth in the tissue. thus, more complex analytics, such 
as high content analysis, have to be refined, since the added z-
dimension to the culture leads to lower resolution on a single 
cell level. Novel approaches based on in vivo imaging technolo-
gies are currently being developed to address this issue.
In general, the field of 3D modeling is lacking consistent pub-
licly available data sets, from in vitro to in vivo evaluations, 
demonstrating that by introducing a 3D-based screen the number 
of false-positives but also false-negatives can be reduced, for 
example by performing a retrospective screen. To move the field 
forward, and increase the likelihood of regulatory acceptance, 
this kind of data set would be required not only to highlight the 
biological similarities to in vivo tumors but also to verify the 
added value of a more complex tumor model over simple cell 
culture in the drug discovery process.
7  Overall discussion 
7.1  Benefits and uses of on-a-chip models
Use of this microengineering approach allows one to develop 
the simplest model possible that retains physiological rel-
evance, and then to add complexity to the system as necessary, 
which is not possible in animal models. the in vitro organ chip 
platform is being applied to model diseases in other organs and 
to predict different drug efficacies and toxicities in humans. 
It is also being leveraged to engineer a “human body-on-a-
chip” with the goal of recapitulating multi-organ physiology 
by linking multiple organ chips through microfluidic chan-
nels. Human organ-on-chip disease models could provide a 
new approach to enhance our fundamental understanding of 
complex disease processes and to enable more rapid, accurate, 
cost-effective and clinically relevant testing of drugs, as well 
as cosmetics, chemicals and environmental toxins. In addi-
tion, it might be possible one day to inhabit these devices with 
cells obtained from different human genetic populations (e.g., 
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9  Conclusions
the routine use of 3D models is not necessarily cheaper than 
animal experiments, but human-derived tissues used under de-
fined test conditions offer several advantages. Issues of species 
extrapolation and ethical questions arising from the use of ex-
perimental animals are avoided. Integrated approaches using 
2D and 3D in vitro methods, as well as bioinformatics, can 
reduce time to market and costs in drug development. they 
also have the potential to improve the accuracy of toxicologi-
cal risk assessment in addition to increasing our understand-
ing of disease mechanisms and drug actions. this provides the 
most important incentive for the further development of 3D 
models: the true cost of a test should be measured by the prob-
ability that a wrong decision in drug discovery or toxicology 
is made based on the test results – and 3D models are expected 
to reduce such errors.
to predict human translation. this will also entail the develop-
ment of appropriate in vitro biomarkers and assays so that re-
sults can be modeled and extrapolated for human translation.
7.3  Quality control
When developing organotypic models, quality control can be 
thought of in terms of model predictivity (i.e., how well does it 
reflect the in vivo situation), as well as technical validity (i.e., 
standardization and reproducibility of the model as a whole) 
(leist et al., 2010). the model should adequately and stably 
reflect the physical and functional parameters of the organ in 
question. Use of 3D modules seems only justified if data can be 
provided that show an improvement over existing 2D models 
for the same organ system or systems.
During initial stages of developing a test using an organotypic 
model, requirements for validation and fitness for purpose are 
low, but once the test progresses to a stage at which data are 
related to regulatory decisions, standardization, reproducibil-
ity, transferability, predictive relevance, applicability domain, 
performance and fitness for purpose become more formalized 
and important. Due to the mass transport difficulties discussed 
above (due to increased complexity) and due to limited through-
put (due to costs, complexity and training, or all of the above), 
validation is challenging. this is worth the effort if applicability 
(due to improved reflection of the in vivo situation), predictivity 
and relevance are clearly demonstrated. 
8  Recommendations to improve the quality of 
organotypic models and increase utility  
for toxicological risk assessment and regulatory 
acceptance
Organotypic models have great potential for utility in toxico-
logical investigations and regulatory risk assessment. Perhaps 
the greatest difficulty for organotypic systems is also their great-
est advantage: organotypic systems are created to mimic the in 
vivo situation as closely as possible. the complexity of the sys-
tem reduces the chance that key aspects of biology are missing, 
but increases the difficulties for reproducibility, quality control 
and interpretation of results. therefore it is necessary to create, 
choose and use models which are as simple as possible, yet as 
complex as necessary, to address a certain question (Hartung, 
2007; Hartung et al., 2004, 2013; leist et al., 2010, 2012a). to 
that end, a call for data-sharing (Breeze et al., 2012; Hanson et 
al., 2011; Murray-Rust et al., 2010) and incorporation of bioin-
formatics approaches and other new and useful technologies for 
data mining and interpretation (Blaauboer et al., 2012; leist et 
al., 2012b) is deemed vital to the future of organotypic models 
in toxicological investigations. the participants in the 3D mod-
elling symposium included these and a number of other recom-
mendations as important for improving the quality and utility of 
organotypic models and increasing the probability of regulatory 
acceptance as a replacement for in vivo testing. the short form 
of the recommendations is summarized in Box 1.
Box 1
Recommendations for improving the quality and utility 
of organotypic models, and increasing the probability of 
regulatory acceptance as a replacement for in vivo testing
1 Design the model “fit for purpose”, i.e., to be applicable 
to the specific task at hand (as complex as necessary, as 
simple as possible).
2 Recruit robust and sustainable cell sources.
3 Reflect human variability (genotypes, transgene expression) 
in cell sources.
4 Utilize and justify appropriate dose ranges (drug 
concentrations).
5 Create a web portal or similar open access database for 
reference data on organotypic models.
6 Openly share detailed protocols for model production and 
use.
7 Couple funding and support for model development to 
adherence to minimal quality control measures.
8 Follow good cell culture practice (GCCP) protocols (Coeke 
et al., 2005), and pay special attention to spatial effects and 
longer-term effects.
9 Strive to apply non-invasive online monitoring.
10 Consider adding omics endpoints, high throughput 
capability and/or modern reporter readouts.
11 Combine 3D model use with in silico technology and 
bioinformatics.
12 Promote 3D models as alternatives to mouse experiments in 
all biomedical communities.
13 Bring together users and developers of 3D models for 
multiple purposes (drug development, toxicological 
investigation, regenerative medicine). 
14 Aim high, but always be aware of current downsides and 
shortcomings.
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